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Background: A number of Mycobacterium tuberculosis (Mtb) genes have been shown to be under 
positive selection pressure in the presence of anti-TB therapy. This results in the selection of drug 
resistant phenotypes associated with genetic changes—which can be point mutations, deletions and/or 
insertions. Some mutations from multiple genes have been documented to be associated with reduced 
susceptibility to anti-TB drugs such as rifampicin, ethambutol, carpreomycin and fluoroquinolones. The 
list is continuously updated as new mutations are discovered and validated. In principle therefore, there 
is an urgent need to design robust molecular diagnostics and more efficacious therapeutic strategies that 
are able to indicate diverse genetic mechanisms behind drug resistance in individual isolates 
Materials and Methods: We used the LightForge system we developed at K-RITH. This LightForge 
system is a fluorescence detection based, highly scalable microfluidic platform. It interrogates 
Mycobacterium tuberculosis strains using Real-Time PCR and High Resolution Melt Analysis (HRMA) 
on a chip.  
Results and Discussion: We have used this LightForge system to identify clinical Mtb strains resistant 
to rifampicin—a frontline drug used to treat tuberculosis, relative to a susceptible strain H37RV, based 
on mutations in the rpoB gene. This system has the potential to contribute towards a low-cost solution 
to diagnosis of multidrug resistant tuberculosis—a current critical global healthcare challenge. The 
interrogation of clinical Mtb isolates—including R35, KZN 605 and Tkk 01-062—using the LightForge 
system has detected mutations linked to rifampicin resistance including single nucleotide 
polymorphisms (SNPs) in a congruous manner with commercial systems. 
Conclusions: In preparation for diagnosis of clinical samples, this LightForge approach is now being 
expanded to incorporate detection of genetic markers linked with resistance to other TB drugs that 
include fluoroquinolones and isoniazid based on mutations in gyrA, katG and Mab-inhA regions of the 
Mtb genome. The scalability of LightForge can also be harnessed to conduct digital PCR (dPCR), a 
critical tool for detecting genetic heterogeneity in Mtb.  
  







(DR)-TB Drug Resistant Tuberculosis 
(DS)-TB Drug Susceptible Tuberculosis 
°C celcius 
µg micro gram 
µl micro liter 
µM microMolar 
µm micro-meter 
2D two- dimensional 
AC Alternating Current 
Al Aluminium  
amol attomols 
BD Becton. Dickinson 
bp Base pair 
BSA Bovine Serum Albumin 
CCD Charge Coupled Device 
CFU colony-forming unit 
cm2 Square centimetres 
cm3 cubic centimeters 
CMOS Complementary metal–oxide–semiconductor 
DC Direct Current 
ddPCR  Droplet digital PCR 
dL Deci-litre 
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DNA deoxyribonucleic acid 
dNTPs deoxynucleotide triphosphates 
dPCR Digital PCR 
dpi Dots per inch 
E. coli  Escherichia Coli 
ELISA Enzyme-Linked-Immunosorbent Assay 
erg 10−7 joules 




HBCs High Burden Countries 
HDMS hexamethyldisilazane 
HIV Human Immunodeficiency Syndrome 
HRMA High Resolution Melting Analysis 
HRP horseradish peroxidase 
INH Isoniazid 
ISFETs Ion-Selective Field Effect Transistors 
ISO International Organization for Standardization 
K kelvin 
kPa kilo-pascal 
K-RITH KwaZulu-Natal Research Institute for TB and HIV 
MDR multi-drug resistant 








mM milli molar 
mm²  square millimeter 
Mtb Mycobacteria tuberculosis 
ng nano gram 




NTM Non tuberculous mycobacteria 
nW Nano-watts 
OFLX Ofloxacin 
PCR polymerase chain reaction 
PDMS polydimethylsiloxane 
pg picogramm 
PMT Photomultiplier tube 
POCs Points of Care 
ppb Parts per billion 
QCM Quartz Crystal Microbalance 
RDTs Rapid Diagnostic Tests 
RFU Relative Fluorescence Unit  
RIF Rifampicin 
RNA ribonucleic acid 
RNA Ribonucleic Acid 
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rpm Rounds per minute 
RRDR Rifampicin Resistance Determining Region 
rRNA Ribosomal ribonucleic acid 
s seconds 
SAV Surface Area to Volume Ratio 
SDA Strand Displacement Amplification 
SiO2 Silicon Dioxide 
SiOH Silicon Hydroxide 
SNP Single Nucleotide Polymorphism 
SPR Surface Plasmon Resonance 
STP Standard Temperature and Pressure 
TB Tuberculosis 
Tm Melting Temperature 
TMA Transcription-mediated amplification 
TMCS Trimethylchlorosilane 
TPD Thermal Particle Detection 
tPSA total prostate specific antigen 
UK United Kingdom 
UKZN University of Kwazulu-Natal 
US United States of America 
USA United States of America 
UV ultraviolet 
Vm-1 Volts per meter 
W watts 
WHO World health organization 
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The dissertation is presented in the following order:  
CHAPTER 1: Introduction  
Presents a brief overview on the current dire status of TB/HIV globally followed by a review of the 
current challenges in fighting these infectious diseases. Finally, the current genomic approaches to TB 
diagnosis are outlined providing the rationale behind moving towards point of care diagnostic platforms. 
 
CHAPTER 2: Microfluidics  
Gives detailed information on the subject of microfluidics as a potential solution to the problems 
outlined in Chapter 1. The chapter provided a literature review on the application of microfluidics in 
diagnostics. It highlights the current knowledge gap that our research has potential to fill. The research 
aims and objectives are also outlined in this chapter. 
 
CHAPTER 3: Materials and Methods 
Provides a full account of the activities implemented in the research. This includes; aims & objectives; 
all consumables; chemical reagents; equipment; software; microfluidic chips’ designing and fabrication 
protocols. 
 
CHAPTER 4: Results 
Describes in detail how the LightForge System (highly scalable microfluidic platform for real-time PCR 
and HRMA) works. A detailed description of how the system was used to detect rifampicin resistance 
conferring mutations in several Mycobacteria tuberculosis clinical isolates is given. The chip design 
optimization towards digital PCR (dPCR) and the potential of the LightForge system to conduct digital 
PCR for heteroresistance detection from the onset are also highlighted. 
 
CHAPTER 5: Discussion 
This chapter focusses on discussing the LightForge system’s SNPs resolution ability in comparison to 
other systems on the market in reference to cost, selectivity, speed, user friendliness, scalability, 
sensitivity, specificity and simplicity. The demonstrated potential application of the LightForge system 
towards digital PCR as well as other applications is discussed. 
 
CHAPTER 6: Conclusions 
This chapter summarises the answers to the questions that this project sought to answer. It also gives an 
insight to the projected future research interest. 
 





1.1. TB/HIV Global Situation 
 
Tuberculosis (TB) is a highly contagious airborne disease that ranks as the second leading cause of 
death by an infectious agent after the Human Immunodeficiency Virus (HIV) [1]. The most recent 
annual global report on Tuberculosis by the World Health Organisation (WHO) indicates that an 
estimated 9 million clinical TB (inclusive of 550 000 children) cases were recorded in the year 2013. 
This number included about 1.1 million cases of TB/HIV co-infection [2]. Of these reported clinical 
cases, 1.5 million deaths were recorded, which included 360 000 cases of TB/HIV co-infection, 510 000 
women and 80 000 children[3]. A recent TB epidemiological study conducted by the WHO identified 
a group of 22 countries with the greatest burden of the TB epidemic with HIV infection being a 
prominent accelerator of the epidemic[4]. The countries belonging to this group have been classified as 
high-burden countries (HBCs) and are responsible for 81% of all reported TB clinical cases globally. 
South Africa is among the HBCs with the third highest absolute number of TB incidence cases reported 
[5]. It is also ranked fifth in terms of estimated undiagnosed active TB cases. However, normalising 
these statistics by taking into account the countries’ population sizes, South Africa has the highest 
incidence and prevalence of TB (per 100 000 people). Statistics further reveal that South Africa has the 
highest number of HIV-linked TB cases and the second highest number of diagnosed multidrug-resistant 
TB (MDR-TB) cases after India among the HBCs[6].  
Based on this state of affairs, South Africa has an unmet need for effective strategies to minimise 
transmission of TB infection within its communities; as well as strategies for early diagnosis of both 
drug susceptible TB (DS-TB) and drug resistant TB (DR-TB). There is also a dire need for timely 
treatment initiation in diagnosed patients. The rate limiting step in the implementation of these strategies 
is the diagnosis step.  
There are several factors affecting the diagnostics infrastructure in South Africa and other developing 
countries. For instance;  
a) People often have to present themselves with TB symptoms at a healthcare providing facility. 
This means that they may never know of their status until it is too late to be treated effectively 
or when they become seriously ill.  
b)  In the majority of cases, people should first test positive for HIV in order to elicit suspicion of 
a possible TB opportunistic infection. Accordingly, patients may remain untested for TB until 
they test positive for HIV.  
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c) The proper TB diagnosis is largely dependent on the sensitivity, specificity and accuracy of the 
test employed. As a result, misdiagnosis still exist in resource limited settings where the lack of 
access to efficient diagnostic tools is the norm.   
d) Often, the turnaround time before the test results become available to the patient is too long (8 
weeks on average in resource limited settings), which is also crippling to the efforts in the fight 
against TB. This is because as long as patients are still unaware of their test results, they still 
remain in the community spreading the disease.  
e)  There is also a need for functional healthcare systems capable of tracing TB positive patients 
ensuring that their treatment is initiated promptly and that they respond appropriately to 
treatment. The absence of such systems is also hindering the efforts to ensure a TB free society 
because most developing countries lack the resources to retest individuals because of the high 
incidence numbers.  
f) Comprehensive diagnosis of TB is also dependent on the healthcare delivery system’s ability 
to track and test persons who made contact with recently diagnosed TB patients. All these 
factors can be addressed through development of large scale and inexpensive diagnostic 
platforms that are capable of screening all at-risk citizens at least once a year [7]. 
1.2. Genomic Approach to TB Diagnosis 
 
Basing on the current genetic findings, spontaneous mutations—that include point mutations, deletions 
and insertions—emanate from the selective pressure due to treatment regimens used for TB. Studies 
have shown this to result in the positive selection of drug resistant phenotypes associated with genetic 
changes—which can be point mutations, deletions and/or insertions. Some mutations from multiple 
Mycobacterium tuberculosis (Mtb) genes have been documented to be associated with reduced 
susceptibility to anti-TB drugs such as rifampicin, ethambutol, carpreomycin and fluoroquinolones[8]. 
Conventional approaches to genomic studies (for instance studies using the GeneXpert machine) heavily 
depend on analysis of genomic material from populations of multiple cells as opposed to single cells 
[9]. The problem of diagnosing using this approach is that the resultant diagnostic indication is 
population averaged and the derived measurements may fail to detect minority events (e.g. mutations) 
occurring in a minority of the cell population [10].  
Conventionally, a 1% subpopulation harbouring drug resistant mutations may not be detectable upon 
first appearance based on population averaged analysis. However, continued treatment may kill off the 
susceptible population allowing the drug resistant sub-population to become dominant, leading to 
treatment failure. In attempts to circumvent population averaged measurements and detect mixed 
infections—occurring at rates of 10-20% in high incident settings[11]—researchers have moved 
towards analyses of genomic material extracted from single cell derived culture isolates. Culture 
diagnostic technique is more sensitive than smear microscopy because it detects a higher proportion of 
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cases among patients with symptoms. It requires further interrogation of positive cultures to distinguish 
TB from Nontuberculous Mycobacteria (NTM). The time to positive results is dependent on bacillary 
load and usually positive by 4 weeks. However, a culture is only confirmed negative after 6 weeks 
incubation. Traditionally culture employs a solid medium for instance coagulated egg (e.g. Löwenstein-
Jensen) or agar (e.g. Middlebrook 7H10) as a base. The drawbacks of solid medium approach are; slow 
bacterial growth (3-4 weeks); and errors due to manual reading of results.  Currently, mycobacterial 
culture methods are gold the standard diagnostic tools in cases of paucibacillary tuberculosis (with low 
Mtb bacilli load), such as in HIV positive patients with smear negative pulmonary tuberculosis and 
children. More sensitive liquid medium culture techniques have been developed for shortening the 
detection of TB bacilli to 2 weeks[12]. Automated systems such as the MGIT 960 detect bacterial 
growth in liquid media using a fluorescence-quenching based oxygen sensor within specialised 
vials/tubes which are inoculated with patients’ specimens[13]. The major limitation of culture methods 
is that they increase the turnaround time for diagnosis by weeks and subsequently intensify the risk of 
other people in communities being exposed to infectious doses of Mtb. Recently research has shown 
that culturing decreases the microbiome diversity thereby causing measurements to deviate from true 
diversity in vivo [8, 14]. In principle therefore, there is an urgent need to design robust molecular 
diagnostic strategies that are able to indicate diverse genetic mechanisms behind drug resistance in 
individual isolates[11]. 
Some of the validated commercially available nucleic acid assays include those from: Roche (Amplicor, 
PCR, FDA-approved)[15], Becton Dickson (BD Probe Tec, strand displacement amplification 
[SDA])[16], Genprobe (Amplified Mycobacterium tuberculosis Direct [AMTD]--FDA-approved)[17], 
transcription mediated amplification [TMA])[18], Hain Lifescience[19], (GenoType Mycobacteria 
Direct, PCR)[20] and Cepheid GeneXpert® MTB/RIF assay[21]. However their impact is being limited 
by their high cost, reliance on skilled personnel and inapplicability at points of care. Furthermore, all 
these quantitative assays are analog in nature, meaning that the fluorescent readouts are an average of 
the total sample volume. This poses a problem in the analysis, as the minority events or the heterogeneity 
of the sample goes undetected.  
To circumvent these problems a novel technique called digital PCR (dPCR) has been developed. Digital 
PCR (dPCR) is a refinement of conventional PCR where the PCR master mix containing minimally 
diluted DNA sample is partitioned into many chambers such that each chamber contains one genome 
or nothing[10]. This “divide and conquer” approach allows individual genomes to be interrogated in 
isolation thus offering more accuracy and less ambiguity than conventional PCR[22]. Corporations such 
as Fluidgm, Life technologies, Bio-Rad and RainDance have developed dPCR systems that are currently 
available on the market at exorbitant prices that are prohibitively expensive for  diseases that principally 
affect poor people in poor social settings. The prices quoted in Table 1.1 [23] for both machine purchase 
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and operational costs are difficult for affected governments to justify expenditure as they are likely to 
consume the entire healthcare budget. 
Table 1.1|Commercial Digital PCR Systems Currently on the Market. 




Fluidigm BioMark HD: $400 per chip 
Corporation US$200,000 - $250,000 
 
Headquarters EPI: $400 per chip 
 
US$100,000 - $150,000 
 
Life Open Array RealTime 
 




 QuantStudio 12K Flex 
$150 per plate 
 US$90,000-$190,000 
 
Bio-Rad QX100 ddPCR System $3 per sample 
Laboratories US$89,000 
 




1.3.  Evaluating the Cepheid GeneXpert® MTB/RIF Assay 
 
Cepheid has developed the GeneXpert® desktop machine that, through the MTB/RIF assay it can 
simultaneously detect Mycobacterium tuberculosis and rifampicin resistance within 2 hours directly 
from sputum[24]. This enables the identification of patients needing second-line drug treatment[25]. It 
has also made it feasible for use in peripheral laboratories and clinics by minimally trained personnel. 
The machine has five versions namely; GeneXpert I; GeneXpert II, GeneXpert IV, GeneXpert XVI and 
GeneXpert Infinity-48 (for one, two, four, sixteen and 48-module configurations respectively)[26]. 
Recent studies have also demonstrated the MTB/RIF assay sensitivity by detecting 98% of smear-
positive TB patients and 70% of smear-negative TB patients[25]. However, this machine has limitations 
that include; short diagnostic cartridge shelf-life; restricted operating environmental conditions; 
unestablished long-term robustness; detects only rifampicin resistance; low scalability; high cost and 
reliance on compulsory annual service maintenance as well as calibration[21]. With the tiered pricing 
for developing countries, each machine costs between US$17,000 and $62,000 while each of its single 
use disposable test-cartridges costs between US$17 and $120[27]. These prices translate to costing 
patients $26.54 per laboratory test and $38.91 per point-of-care test. In practical consideration, if each 
GeneXpert run takes 2 hours, when a GeneXpert I is used, only 12 patients can be diagnosed in a day. 
Therefore for a disease that affects millions of poor people, it is unsustainable to be charging them 
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US$26.54 - $38.91 at such a low service execution rate.  In 2014, the South African government decided 
on GeneXpert roll-out to smear microscopy laboratories; the expected volumes were each for 274 
laboratories or 4020 points of care. The idea was to test 2.6 million pulmonary TB suspects. The total 
cost for national placement of GeneXpert at laboratories was projected at US$71 million per year and 
US$107 million per year for point-of-care placement[28]. However, with the above stated shortcomings 
of the GeneXpert, there is no reason to substantially justify this additional expenditure to the national 
health budget. 
 
1.4. Towards Point of Care (POC) TB Diagnosis 
 
As far as TB diagnosis, treatment and management are concerned, the use of traditional "heavy" lab 
instrumentation for diagnostic tests has been essentially important for their accuracy[29]. However, with 
the current high demand for frugally sustainable alternatives with user friendly analytical platforms, 
there is an urgent need for simple rapid diagnostic tests (RDTs) for diagnosis at points of care (POCs). 
As per guidelines an ideal POC device should have its minimal strengths adhering to WHO’s 
ASSURED (affordable, sensitive, specific, user-friendly, rapid, equipment free and be deliverable to 
the needing parties) criteria that condense specification goals for point of care testing [30].  Figure 1.1 
illustrates the goals towards the true POC diagnosis approach and the time it saves towards patient 
recovery. With technologies such as bioelectronics, microfabrication as well as nanofabrication hitting 
the strides, novel methods and tools for TB diagnosis are being developed. These emerging tools are 
showing great potential to provide efficient, low cost and miniaturized microfluidic diagnostic platforms 
for Mycobacterium tuberculosis.   
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Figure 1.1|Schematic illustration of the vision towards an ideal point of care (POC) diagnosis. The figure is 
comparing point of care testing and the traditional testing approaches in parallel. It illustrates the goals towards 
a true POC diagnosis approach and the time it saves towards patient recovery. It can be seen that the projected 
POC allows patients to be tested and treated at bedside or in the community thus significantly simplifying the 
costly, laborious and long traditional approach. The traditional approach involves; patient transportation; patient 
hospitalisation; patient specimen collection; cumbersome lengthy diagnostic testing; manual data capturing and 
analysis; and finally medicine prescription and patient recovery if they are still alive. The highlighted recovered 
lost time can be crucial for: i) preventing loss of lives due to curable diseases such as TB or ii) minimising the 






                                                          
a Concept adapted from http://aetcnmc.org/curricula/promoting/mod5_1.html 
 





2.1. Microfluidics Definition 
 
Microfluidics is a science involving building devices that precisely manipulate and control minute 
volumes (10-9 – 10-18 litres) of fluids and particles through the use of channels with widths ranging from 
tens to hundreds of micrometres[31]. There are scenarios where reagents are very expensive, therefore 
microfluidics has become important as it preserves the functionality of the assay while saving time and 
reagents. Microfluidics has a rich history that dates back as early as the 1950s when it became the basis 
of inkjet printer technology[32]. Later the 1970s saw the compacted gas chromatographs being invented 
also based on this principle[33]. As the 1980s approached the first silicon micro-machining based micro-
valves and micro-pumps were realized [34-36]. Then the three decades that approached to date, involved 
extensive research in the development of specialized microfluidic components designed to transport, 
meter, mix, valve, concentrate and separate fluids[37]. 
 
2.2. Underlying Principles of Microfluidics 
 
In contrast to macrofluidics—which deals with the realm of millilitres to litres, there are several forces 
that dominate fluid flow within channels with microscale dimensions[38]. Studies have proven that the 
normal functional efficiency is not conserved when currently existing macroscale devices are shrunk to 
microscale. Miniaturization comes with domination of effects that include laminar flow, diffusion, 
fluidic resistance, surface area to volume ratio and surface tension[39]. However, an understanding of 
these parameters in the microscale allows us to manipulate them to our advantage. 
2.2.1. Reynolds Number 
 
A description of viscous fluidic motion (laminar or turbulent) is given by the dimensionless Reynolds 
number (Re) parameter which is calculated by: 
 






where 𝜌 is the fluid density, 𝜈 is the characteristic velocity of the fluid, 𝐷ℎ is the hydraulic diameter that 
is calculated based on the cross-section of the channel and 𝜇 is the fluid viscosity[40]. For a fluidic flow 
to be classified as laminar (See section 2.2.2. for a more detailed explanation on laminar flow), the 
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Reynolds number as calculated by the above formula needs to be less than 2300. Signs of turbulence 
begin to manifest as the Re approaches 2300. When Re surpasses 2300, the motion is rendered turbulent 
by definition. This reason declares macroscale platforms challenging to work with because they are 
largely considered turbulent. Inversely, the laminar motions that exist in microscale systems make them 
more predictive and easier to work with[41]. 
2.2.2. Laminar Flow 
 
Contrary to turbulent flow that is considered chaotic and difficult for predicting the location of a particle 
in a stream of fluid as a function of time, particles in laminar flow can have a well-defined function of 
time. Microfluidics guarantees this laminar flow of fluids[42, 43]. Figure 2.1a (below) shows an 
interesting laminar flow illustration of how multiple streams flowing in contact with one another will 
only mix by diffusion and not by any other mechanism. The non-uniformity of this multiple stream 
diffusive mixing within the same channel has been proven under certain conditions [44]. Researchers 
have capitalized on this phenomenon to predictively perform assays and size dependent sorting of 
particles. As also illustrated in Figure 2.1b (below), laminar flow has also been harnessed to 
compartmentalise fluids into droplet packets. The components of adjacent packets only mix by diffusive 
forces, other than that, the composition in each packet remain relatively maintained. These packets for 
instance can be manipulated to allow multiple reactions or cellular analysis [45]. 
 
Figure 2.1|Microchannel fluid dynamics (a) Two adjacent flowing streams only mix by diffusion. As the 
duration of the streams’ contact increases the degree of diffusion between the streams under study increases. 
(b) The fluid is initially flown vertically following direction 1 with minimal diffusion effects along the 
horizontal channel. When the fluid is subsequently flown along direction 2, a fluid packet is created from 
stream 1 and moves along the horizontal channel. (Adapted from a 2002 Physics and applications of 
microfluidics in biology annual review of biomedical engineering) [41]. 
 
 




Diffusion is a mechanism of Brownian motion by which a concentrated group of particles distributes 
out as a function of time and this ultimately leads to a uniform concentration of particles in a fixed 
volume container. The equation that models diffusion in one dimension is given by; 
 𝑑2 = 2𝐷𝑡 
 
(2) 
where 𝑑 is the distance travelled by a particle in time 𝑡, while 𝐷 is the diffusion constant of the particle 
[46]. Diffusion effects become critically exacerbated in microsystems because according to the equation 
above distance varies to the square power. As an illustration, haemoglobin (𝐷 = 7× 10 -7 cm2s-1) has 
been shown to take 106 sec to diffuse over 1 cm, but only 1 sec to diffuse 10µm distance [41]. This 
means that diffusion is a negligible parameter in macrosystems. However, in microsystems it becomes 
a critical effect to neglect. In fact, when dealing with microfluidic systems, diffusion can be relied on 
for mixing reagents, thus preventing the need for expensive and complex mixers often required in 
macrosystems. Researchers have harnessed these diffusion effects in microsystems to create 
concentration gradients with high complexity for various applications [47]. 
2.2.4. Resistance 
 









where 𝑄 is the flow rate,  Δ𝑃 is the pressure drop across the microchannel, and 𝑅 is the microchannel 
resistance [48]. An understanding of the geometry of microfluidic channels allows us to predictively 
harness resistance for microfluidic manipulation. If we consider the most common circular 
microchannel geometry, the resistance is given by the equation; 
 






Where 𝜇 is the fluid viscosity, 𝐿 is the microchannel length, and 𝑟 is the channel radius [49]. However, 
if we change the geometry to a low aspect ratio (ℎ ≈  𝑤) rectangular the expression for resistance 
becomes much more complicated and follows the following equation; 
 
  School of LM & MS                                           17                                                        University of KwaZulu-Natal 
 
 






















where 𝑤 is channel width while ℎ is the channel height. However for rectangular microchannel 
geometry with high aspect ratio (either ℎ ≪  𝑤 or 𝑤 ≪ ℎ ) the resistance can be computed using the 
following equation [50]; 
 






2.2.5. Surface Area to Volume Ratio 
 
With miniaturisation to microscale, surface area to volume ratio (SAV ratio) becomes an important 
factor. In microsystems, a small decrease in the microchannel dimensions is accompanied by an increase 
in the SAV ratio. With high SAV ratio in microfluidic systems, reaction rates and thermal transfer occur 
at faster rates. This high SAV ratio in contrast to macroscale vessels—including flasks, tubes and 
dishes—makes microfluidic systems ideal for close mimicry of in vivo conditions where the SAV ratio 
is typically very high. The high SAV ratio is however only disadvantageous for the reason that it allows 
particles to easily adsorb to the surface of the channels thus reducing the efficiency of fluid motion [51]. 
2.2.6. Surface Tension 
 
The resulting force of cohesion between liquid molecules at the liquid/gas interface is called surface 
tension[52]. This force presents one of the most important differences between macroscale and 
microscale fluidic motions. Surface tension can assist in propelling fluid flow through exploitation of 
capillary action. This is a phenomenon that is commonly described as wicking. It occurs when 
intermolecular forces between the fluid and the narrow microchannel’s surface overcome those within 
the fluid itself, such that it is drawn through the channel[53]. Researchers have found a way of inhibiting 
or inducing flow by altering the hydrophobicity of the channel’s surface. Using various physicochemical 
modifications, scientists have created hydrophobic stops at locations of interest within microfluidic 
circuits so that aqueous solutions can be impeded upon reaching that location[41]. This principle based 
on surface tension has been applied to droplet-based digital microfluidics. Often employed are two 
immiscible phases where the continuous phase is a hydrophobic fluid such as oil or air. Since most 
biological samples are in aqueous solutions, they form the disperse phase of the system[54]. The 
mathematical description of the pressure that a liquid surface with perpendicular radii of curvature given 
by 𝑅1 and 𝑅2 generates can be computed using the Young-LaPlace equation; 
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where 𝛾 is the free energy of the liquid surface. If virtual walls are involved, the 𝑅 defining the wall 
length approaches infinity such that the relation reduces to; 






This gives the pressure that is present at the liquid boundary existing between two infinitely large 
parallel plates that have a 2𝑅 distance apart. If we consider a spherical surface where 𝑅1 =  𝑅2 the 
relation reduces to; 
 






This relation makes it easier to compute the pressure contained within a liquid spherical drop[55]. 
2.3. Microfabrication 
 
2.3.1. Clean Rooms 
 
To guarantee acceptable yields, the processes of microfabrication (manufacturing microfluidic devices) 
must be carried out within a microfluidic clean room[56]. This room is specially designed in such a way 
that the size and the quantity of particulates that are airborne are critically controlled. Other parameters 
that are also controlled with high specificity include temperature, air pressure, humidity, vibration and 
lighting (yellow is the standard to avoid activation of photo-reactive resist). Classification of 
microfluidic clean rooms is based on the quantity and size of particulates that they allow per unit volume 
of air. Table 2.1[57] summarises the guidelines used by the International Organisation for 
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Table 2.1|ISO 14644-1 Classification of Clean Rooms. 
  Highest Particle Count per Cubic Meter   
Class ≥ 0.1µm ≥ 0.2µm ≥ 0.3µm ≥ 0.5µm ≥ 1µm ≥ 5µm 
ISO 1 10 2     
ISO 2 100 24 10 4   
ISO 3 1,000 237 102 35 8  
ISO 4 10,000 2,730 1,020 352 83  
ISO 5 100,000 23,700 10,200 3,520 832 29 
ISO 6 1,000,000 237,700 102,000 35,200 8,320 293 
ISO 7    352,000 83,200 2,930 
ISO 8    3,520,000 832,000 29,300 




There are numerous lithography techniques for fabrication of microstructures. On the basis of energy 
beams involved, lithography techniques can be further subcategorised into photolithography, electron 
lithography, X-Ray lithography and ion lithography. However, photolithography is the most popular 
technique for microfluidic devices’ fabrication [57]. Photolithography is limited to two-dimensional 
lateral structures and it employs a photosensitive emulsion layer called resist which is receptive of a 
desired design from a transparent mask. In most microfluidic applications that require complex 
structures, a mask derived from Autodesk AutoCAD software design is printed on a plastic transparency 
film by a high resolution (greater than 5000 dpi) commercial printer. There are three main processing 
steps describing photolithography illustrated in Figure 2.2: 
i. Alignment Process: this involves the lateral positioning of the mask and the resist spin-coated 
substrate with adjustment of distance separating the mask and the substrate.  
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Figure 2.2|Schematic illustration of standard photolithographic protocol for master fabrication. Described 
in sequential order are the steps involved in photolithography. The first step involves coating the wafer 
with photo-reactive resist. A pre-exposure soft bake step follows to harden the photo-reactive resist. A 
photo-mask is placed in proximity or in contact with the photo-reactive resist coated wafer. The wafer is 
then exposed to UV-light using a photo-mask aligner. Depending on the nature of the photo-reactive resist 
employed (positive or negative), the cross-linking occurs accordingly. A post-exposure then carried out 
paving way for the development of the designed micro-features on the mold/master using the developing 
solutions. The masters are then finally rinsed and dried to complete their fabrication.b 
 
                                                          
b Concept redrawn after adaptation from http://www.photochembgsu.com/applications/photoresists 
 
  School of LM & MS                                           21                                                        University of KwaZulu-Natal 
 
ii. Exposure Process: This process can be summarised as optical shining of the resist layer, thus 
transferring designs from the mask transparency to the photoresist by chemically altering the 
properties of the shone regions. 
iii. Development Process: This is a process of dissolution (for negative resist) or etching (for positive 
resist) of the resist design in a developer solution to generate the desired features on the 
mold/master.  
In general, photolithography is categorised into contact printing, proximity printing and projection 
printing. As the names suggest, the first two techniques involve bringing the mask close to the substrate; 
for contact printing, the transparent mask even touches the photoresist layer. For contact and proximity 









where 𝜆 is the wavelength and 𝑠 is the distance between the photoresist layer and the mask. However 








where 𝑁𝐴 is the numerical aperture of the lens involved in the imaging [58]. 
2.3.3. Soft Lithography 
 
Soft lithography is a microfabrication technique that typically use a two-component polymer (elastomer 
and curing agent) called polydimethylsiloxane (PDMS) for molding using the photoresist masters 
obtained from photolithography [59]. The features of the PDMS device are only limited by the master 
molds from which it is moulded from. This has greatly revolutionised the fabrication of microstructures 
with high degree of complexity using PDMS. This revolution has seen devices with complex 
multidimensional layers being fabricated for various applications.  The popularity of soft lithography 
over glass/silicon micromachining emanates from it being less expensive and more suitable for 
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Table 2.2|PDMS Physical and Chemical Propertiesc  
Property Characteristics Consequence 
Optical Transparent; UV cut-off, 
240nm 




Insulating; breakdown voltage, 
2× 107 Vm-1 
Allows embedded circuits; intentional 
breakdown to open connections 
 
Mechanical 
Elastomeric; tunable Young’s 
modulus, typical value of 
~750kPa 
Conforms to surfaces; allows actuation by 





conductivity, 0.2 W(m·k)-1; 
coefficient of thermal 
expansion, 310µm(m·°C)-1; 
stable up to ~300°C 
Can be used to insulate heated solutions; does 





Low surface free energy 
 ~20 erg cm-2 
 
Replicas release easily from moulds; can be 
reversibly sealed to materials; not wetted by 





Low permeability to liquid 
water; permeable to gases and 
nonpolar organic solvents 
Contains aqueous solutions in channels; allows 
gas transport through the bulk material; 
incompatible with many organic solvents 
 
Reactivity 
Inert; can be oxidised by 
exposure to a plasma 
Unreactive toward most reagents; surface can be 
etched; can be modified to be hydrophilic and 













                                                          
c Adapted from Basic microfluidic and soft lithographic techniques by Tang et al. 
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The Figure 2.3 (below) shows the schematic illustration of steps involved in soft lithography that 
include PDMS dispensation, PDMS curing via oven baking, cutting the chip and punching inlet and 
outlet ports and bonding the chip to a holder substrate. 
 
Figure 2.3| Schematic illustration of standard soft lithographic protocol for PDMS fabrication using the 
silicon wafer. Illustrated in sequential order are steps involved in soft lithography describing; PDMS 
dispensation; PDMS baking in an oven ensuring the PDMS to cure. Once cured the device is carefully cut 
along its periphery of the master; peeled off the master and input/outlet ports be punched with a punch press. 
The device is then placed on a pre-treated substrate such as a glass slide. The resulting hybrid device is then 
oven baked to ensure bondage of the glass substrate to the PDMS device.d 
 
                                                          
d Concept redrawn after adaptation from http://www.elveflow.com/microfluidic-tutorials/soft-lithography-
reviews-and-tutorials/ 
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2.4. Microfluidic Device Detection Methods 
 
Detection mechanisms employed by biosensors that are integrated on microfluidic devices can be 
broadly classified into four different categories namely optical, electrochemical, thermal and 
mechanical [62]. Every biosensor design constantly aims to address and maximise strengths in 
sensitivity and selectivity. This makes detectors in microfluidic systems similar to those applied in 
conventional biosensors. However, with miniaturisation we approach the realm of lower volumes 
and concentrations. This realm therefore requires a low cost, highly selective and highly sensitive 
detector compatible with automation. The Figure 2.4 (below) shows a schematic illustration of 
biosensor principle. 
 
Figure 2.4| Schematic illustration of biosensor principle. The scheme shows the biomaterial detection 
mechanisms employed by biosensors that are integrated on microfluidic devices. There are several transducers 
that can be broadly classified into the shown four different categories namely optical, electrochemical, thermal 
and mechanical. After a specific signal recognition, the signal is transduced through the above stated 
mechanisms. This pave way for amplifiers such as the photomultiplier tubes (PMTs) to enhance the signal 
intensity so that it can be readable for analysis by a computer[63, 64]. 
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2.4.1.  Optical Detection Based Devices 
 
In microfluidic biosensors, optical detection methods mostly rely on mechanisms that involve 
absorbance, fluorescence, chemiluminescence and surface plasmon resonance (SPR). In pursuit of high 
sensitivity and specificity, microscopes, lasers, spectrophotometers, charge coupled devices (CCDs) and 
photomultiplier tubes (PMTs) are still being coupled to microfluidic devices[65]. However, these 
fundamental components of optical detection are still very expensive and difficult to miniaturise. Given 
that for a true point-of-care system, microfluidic devices need to be cheap and user friendly, therefore 
this is a challenge that all future systems should aim to address [66].  
2.4.1.1. Absorbance Based Devices 
Absorption spectrometry is a traditional chemical analysis technique of determining the absorbance (𝐴) 
of a specific wavelength of incident light by an analyte based on the Beer-Lambert law below; 
                                                     𝐴 =  −𝑙𝑜𝑔10
𝑃
𝑃0
= 𝜀𝑐𝑙 (12) 
 
Where, 𝑃 is the emergent beam radiant power (intensity); 𝑃0  is the incident initial radiant power 
(intensity); 𝜀 is the absorptivity (extinction coefficient) of sample solution; 𝑐 is the concentration of the 
absorbing analyte solution; and 𝑙 is the path length of the cell [67]. In conventional laboratory settings 
UV absorption spectroscopy is mainly used to detect absorbance. Gustaffson and his team described 
their work on electrochromatographic separation on-chip utilising UV-transparent SiO2 waveguides that 
they arranged in a silicon substrate and integrated within channels of a microfluidic system. Vykoukal 
et al described their absorbance based glucose colorimetric enzyme real-time assay that relies on CMOS 
image sensing [68]. A 5 hour long absorbance related assay for a cancer biomarker (HE4) was developed 
by Wang and team based on colorimetric sandwich ELISA. This assay works in conjunction with a 
CCD camera and has its resolution pegged at 19.5ng/mL [69]. Another on-chip absorbance detection 
platform was developed by Jokerst and team in 2012. Their colorimetric enzyme based assay detects E. 
coli, Salmonella and Listeria within 12 hours with a resolution of 10 CFU/cm3 [70]. Despite these few 
attempts, microfluidic systems employing absorbance as a mechanism of detection are not very popular. 
The main drawback is that, a considerably long path length through which a specific wavelength beam 
of light has to travel within the sample at lower concentration is required for efficiency of this method. 
This renders the application of this detection method in microfluidic systems very challenging because 
the extremely narrow nature of microfluidic channels works against sensitivity to absorbance 




  School of LM & MS                                           26                                                        University of KwaZulu-Natal 
 
Table 2.3| Summary of Devices Based on Absorbance Principle of Optical Detection 










- ††  [68] 
Enzymatic Assay Sensor   
Cancer HE4 Colorimetric 
CCD 
Camera 




ELISA   
E. Coli; 




Listeria Enzymatic Assay (No sensor)   
   ͣ Potential applicability for point-of-care: † Low; ††Moderate; ††† High 
2.4.1.2. Fluorescence Based Devices 
 
Fluorescence process involves a fluorophore or fluorescent dye undergoing three stages namely; 
excitation, excited state lifetime and emission[71]. The detection mechanism involves absorption of 
molecular light triggering emission of longer wavelength relative to the excitation wavelength[72]. In 
various applications fluorescent dyes derived from small molecules, proteins or quantum dots 
conjugated to proteins, nucleic acids or lipids have been developed[73-76]. This highly sensitive and 
highly selective fluorescent labelling has attracted diverse applications in microfluidic systems. 
Currently off-chip CCDs, microscope optics and PMTs coupled to these microfluidic systems still 
dominate fluorescence detection but work is underway to miniaturise and reduce their complexity[77]. 
As examples of fluorescence based microfluidic detection systems, Lee and his team used an 
optofluidics approach to develop a microscope technique that image a protozoan descent parasitic 
species Giardia lamblia cysts commonly found in environmental waters. Their technique is based on a 
CMOS image sensor with a time of analysis (~1 s) and the resolution is described with a focal plane of 
0.8 µm [78].  Ramalingam and colleagues reported their work on real-time PCR based pathogen 
detection. They demonstrated parallel detection of genomic DNA belonging to multiple water borne 
pathogens namely; Aeromonas hydrophilia, Klebsiella pneumonia, Staphylococcus aureus and 
Pseudomonas aeruginosa with a resolution of about 50 CFU/mL using a CCD camera to detect 
fluorescence of EvaGreen dye which intercalates to DNA [79]. For environmental application, Yildirim 
and colleagues developed a competitive aptamer-based optical biosensor employing inorganic 
photodiodes that rapidly detects (in 10 min) 17-β-estradiol in water samples with a resolution of 0.6 
ng/mL [80]. Another application was reported by Ishimatsu and colleagues when they developed a 
portable thin film organic photodiode that detects (within 5 min) alkylphenol polyethoxylates 
(resolution 2-4 ppb) using flow fluorescence based competitive immunoassay with magnetic micro-
beads within a microfluidic channel [81]. The major drawback that affect fluorescence detection within 
microfluidic systems is that, the sensitivity is usually compromised by background signals emanating 
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from auto-fluorescence by the sample matrix. Currently the cost of fluorophores and fluorescent dyes 
is very high and often the fluorophores come with low shelf lives. Apart from factors such as 
temperature and pH influencing the shelf lives, the protocols for fluorescent labelling involve complex 
manipulation of fluid within micro-channels thus affecting the automation of assays[66]. Table 2.4 
(below) summarises some of the work done with the application of fluorescence based detectors in 
microfluidic devices. 
Table 2.4 |Summary of Devices Based on Fluorescence Principle of Optical Detection 




interest Assay Technology Duration at POC   ͣ
Giardia 
Lamblia Microscopy CMOS image ~ 1 s Focal plane  † [78] 
cysts   sensor of 0.8 µm   
Bacterial DNA PCR CCD camera Real-Time 
~50 
CFU/mL †  [79] 
17-β Competitive Inorganic 
~10 min 0.6ng/mL †† 
 
estradiol aptamer Photodiodes  [80] 
Alkylphenol Competitive Organic 
~5 min 2-4ppb †† 
 
polyethoxylates immunoassay Photodiodes  [81] 
   ͣ Potential applicability for point-of-care: † Low; ††Moderate; ††† High 
 
2.4.1.3. Chemiluminescence Based Devices 
 
Chemiluminescence is an optical detection method that involves the emission of light as a result of 
occurrence of a chemical reaction. When an analyte interacts with a receptor, a photochemical reaction 
occurs directly or with the aid of an enzyme label. This method has also been at the centre of attraction 
in many on-chip microfluidic technologies because it has no need for excitation light sources and 
emission filters. This results from the fact that, the photochemical reactions are very specific; therefore 
the likelihood of interference by matrix or background emission is largely minimized[82]. Xiang and 
colleagues have developed a 25 min long microfluidic based capillary chemiluminescence 
immunoassay for Hepatitis B antigen detection. Their biosensor technology employed a microplate 
reader and was able to register a limit of detection as low as 0.3ng/mL [83]. Hao and team developed 
an on-chip sandwich immunoassay for carcinoembryonic antigen detection using a PMT and were able 
to register a detection limit as low as 20 pg/mL [84]. Yang and colleagues also developed a 1 hour long 
sandwich immunoassay for Staphylococcal enterotoxin B detection using a CCD camera to obtain limit 
of detection as low as 0.1 ng/mL [85]. Harnessing the HRP luminol reactions coupled with inorganic 
photodiodes, Caputo and team were able to detect anti-HRP antibodies on-chip at a limit of detection 
of 0.2 amol within 1 h [86]. On-chip Streptavidin detection in real-time using HRP luminol reactions 
coupled with inorganic photodiodes was achieved by Lin and team at 4.76 nM limit of detection [87]. 
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Wojciechowski and team successfully detected Staphylococcal enterotoxin B (within 60 – 70 s) by 
coupling an organic photodiode system to their sandwich immunoassay and obtained a limit of detection 
of 0.5 ng/mL [88].The major drawback of chemiluminescence is that, the photochemical signal is quite 
weak and usually requires sophisticated highly sensitive and computerised ultra-weak luminescence 
analysers to detect. Table 2.5 (below) summarises some of the work done with chemiluminescence 
detection application in microfluidic devices. 
Table 2.5| Summary of Devices Based on Chemiluminescence Principle of Optical Detection 




interest Assay Technology Duration at POC   ͣ
Hepatitis B Capillary Microplate 
25 min 0.3 ng/mL † 
[83] 
antigen immunoassay reader  
Carcinoembryonic Sandwich 
PMT - 20 pg/mL † 
[84] 
antigen immunoassay  
Staphylococcal Sandwich CCD 
> 1 h 0.1 ng/mL † 
[85] 
enterotoxin B immunoassay Camera  
Anti-HRP HRP-luminol Inorganic 
> 1 h 0.2 amol †† 
[86] 




4.76 nM †† 
[87] 
reactions Photodiodes  
Staphylococcal Sandwich Organic  
60 - 70 s 0.5 ng/mL ††† 
[88] 
enterotoxin B immunoassay Photodiodes   
 ͣ Potential applicability for point-of-care: † Low; ††Moderate; ††† High 
 
2.4.1.4. Surface Plasmon Resonance (SPR) Based Devices 
 
SPR optical detection methods are dependent on determining the change in the refractive index at a 
heavy metal (usually gold or silver) surface. This metal surface is typically functionalised with probe 
molecules usually antibodies, antigens or nucleic acid strands. As being illustrated in Figure 2.5 [89], 
when an incident beam of light of specified wavelength passes through a prism at a specific angle 
towards a thin metal film, it excites a propagating surface plasmon at the surface of the metal film. As 
shown in Figure 2.5, the SPR angle is distinctively dependent on the mass of particles deposited on the 
opposite side of the metal thin film surface. The only scenario that changes the SPR angle is when the 
complementary analytes bind to the probe-functionalised metal surface registering a change in the mass 
of the surface film. In most detectors, this mass change at the metal surface film undergoes a 
transduction pathway through impacting a change in the resonant angle and this change can be recorded 
in real-time by plotting the resonance signal (a measure of mass change at the metal film surface) as a 
function of time[90, 91]. Krupin and colleagues have developed a real-time protein adsorption technique 
for Bovine Serum Albumin (BSA) detection using an infrared camera to obtain limit of detection as low 
as 12 pg/mm² [92]. Another SPR based real-time assay was developed by Ouellet and team, where they 
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detected human α-thrombin in a label free immunoassay using a CCD camera to reach a limit of 
detection of about 5 nM [91]. Foudeh and team using a CCD camera were also able to detect bacterial 
rRNA in an on-chip enzymatic colorimetric assay within 3 hours reaching a 0.45 fM detection limit 
[93]. Currently SPR technology has displayed tremendous sensitivity towards above -mentioned 
analytes; however, sophisticated equipment is still required to record SPR measurements.  
 
Figure 2.5| Illustration of the SPR principle. This figure illustrates that the surface is typically 
functionalised with probe molecules usually antibodies, antigens or nucleic acid strands. As being 
shown, when an incident beam of light of specified wavelength passes through a prism at a specific 
angle towards a thin metal film, it excites a propagating surface plasmon at the surface of the metal 
film. The SPR angle is distinctively dependent on the mass of particles deposited on the opposite side 
of the metal thin film surface. The only scenario that changes the SPR angle is when the 
complementary analytes bind to the probe-functionalised metal surface registering a change in the 
mass of the surface film. 
Another factor that poses challenges is the microfluidic fabrication process due to the cost and 
complexity of embedding SPR sensors within the chip. SPR readings are also strongly affected by 
environmental conditions such as temperature and this ultimately has an impact on sensitivity of the 
method[94]. Another disadvantage is the gold and silver nanoparticles that have been largely applied; 
these precious metals are not sustainable for application in disposable point of care devices on grounds 
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Table 2.6|Summary of Devices Based on SPR Principle of Optical Detection. 




interest Assay Technology Duration at POC   ͣ






Albumin Adsorption Camera  
Human Label-Free CCD 
Camera 
Real-Time ~5 nM †† 
[91] 









   ͣ Potential applicability for point-of-care: † Low; ††Moderate; ††† High 
 
2.4.2.   Electrochemical Detection Based Devices  
 
Detection using electrochemistry is a technology that relies on the interaction between chemical species 
with electric probes or electrodes[95]. This cross interaction culminates in generation of diverse signals 
that include potential, current, capacitance, inductance, conductance or impedance among others[96]. 
For the electrochemistry to occur and be measurable, charge or electron transfer (via reduction and 
oxidation reactions) has to occur through induction via the following major underlying principles[97]. 
(i) An electric current has to be passed through the analytical sample via an electrode system. (ii)The 
occurrence of a specific chemical reaction has to allow the electrode to register a response[66]. 
Electrochemical detection has numerous advantages that make it attractive for microfluidic applications. 
Electronics are very compatible with miniaturisation and this has inspired miniaturisation in various 
fields including fluidics. Electrochemical detectors usually have high sensitivity, low detection limits 
and are ideal detecting analytes usually embedded in complex matrices[97]. The commonly applied 
electroanalytical detection principles lie in categories of potentiometry, amperometry and 
conductometry or impedomerty[66]. 
2.4.2.1. Potentiometric Devices 
 
Potentiometric biosensors measure the cell potential difference in an open circuit (at virtually zero 
current)[98]. The sensors produce a logarithmic concentration response allowing the measurement of 
extremely minute concentration changes with also a potential to do so in a continuous flow system. 
However, even with more refined ion selective field effect transistors (ISFETs) that can detect biological 
recognition events, potentiometry still has lower selectivity and higher detection limits in certain sample 
matrices[95]. Another set of drawbacks with this technology include facts that material immobilization 
techniques, packaging and fabrication are still very complex and expensive. Liao and colleagues have 
developed a potentiometry technique for detecting multiple biologically important ions using ion 
selective platinum microelectrodes. Their method was sensitive enough to obtain a limit of detection as 
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low as 10 µM[99]. Chou and team used a chemical species selective membrane sensor to 
potentiometrically detect glucose with a technique having a limit of detection of about 100 mg/dL[100]. 
Table 2.7 (below) summarises some of the work on potentiometric detection in microfluidic devices. 
Table 2.7 |Summary of Devices Based on Potentiometric Principle of Electrochemical Detection. 




interest Assay Technology Duration at POC   ͣ
Multiple  Ion Platinum _ 
10 uM †† 
[99] 
ions Selectivity microelectrodes   
Glucose 




Selectivity Sensor   
a Potential applicability for point-of-care: † Low; ††Moderate; ††† High 
 
2.4.2.2. Amperometric Devices 
 
Amperometric biosensors measure the current linked to redox reaction(s) by an electrochemically active 
analyte at an interface of a working electrode relative to a reference electrode under conditions of 
constant potential difference[101]. In principle, there is a linear relationship between the analyte 
concentration and the registered current[102]. In instances where bio-molecular analytes do not a have 
a direct electron exchange relationship with the electrodes, redox intermediators that reversibly 
exchange electrons between the analyte and the electrode are employed[103]. The fact that most bio-
molecular analytes do not have direct electron transfer relationships with electrodes poses limitations 
of this technology as very few redox reactions intermediators have been characterised. Gau and 
colleagues successfully harnessed a nucleic acid hybridisation assay coupled to an amperometric sensor 
to detect E. coli rRNA within 40min and with a limit of detection of about 1000 CFUs[104]. Using an 
immune-filtration assay and an amperometric sensor Abdel-Hamid and team were able to detect E. coli 
cells within 30 min at a limit of detection of about 100 cells/mL[105]. An ELISA based amperometric 
technique for Hepatitis B surface antigen detection at a detection limit of 0.005 μg/mL was also 
developed by Tang’s team[106]. Table 2.8 (below) summarises some of the work in which 
amperometric detection was applied in microfluidic devices. 
Table 2.8 |Summary of Devices Based on Amperometric Principle of Electrochemical Detection. 




interest Assay Technology Duration at POC   ͣ
E. coli Hybridisation Amperometric 
40 min ~1000 CFUs † 
[104] 
rRNA Assay sensor  










0.005 μg/mL † 
 
(HBsAg) sensor [106] 
   ͣ Potential applicability for point-of-care: † Low; ††Moderate; ††† High 
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2.4.2.3. Conductometric or Impedimetric Devices 
 
Conductometric or impedimetric techniques measure the conductance or impedance of solutions that 
have ions (cations/anions) as charge carriers. Through AC electric field application between two 
electrodes, the conductometer/impedometer gathers the generated signals indicating changes in 
amplitude and/or phase angle. The amplitude signal is an indicator of serial resistance within the circuit 
under study. However, if DC electric field is applied, pure resistance signals are given and this property 
has been harnessed to make simpler instruments that are compatible with miniaturized microfluidic 
systems. The major demerit associated with conductometry in microfluidics is that if DC electric signal 
is applied through capillaries and microchannels, the potential difference is largely localised on the 
electric double layer on the electrode surface opposed to the analyte solution[107]. Bonanni and various 
teams have extensively applied gold nanoelectrodes for impedimetric genomic enterogation of various 
pathogens that include Salmonella spp, H1N1 swine flu virus and Cystic Fibrosis related DNA. Table 
2.9 (below) summarises some of the work that applied the principle of impedimetry in microfluidic 
devices [108-111]. 
Table 2.9 |Summary of Devices Based on Impedimetric Principle of Electrochemical Detection. 




interest Assay Technology Duration at POC   ͣ
Salmonella  Double tagging Impedimetric _ _ 
† 
[111] 
spp PCR products Sensor  
DNA 
DNA Gold _ 
~3 µM † 
[109] 
Hybridisation Nanoelectrodes  
H1N1 virus DNA Probe Nanoelectrode _ 
577 pmol/L † 
[110] 




_ 100 pM † [108] 
Related DNA Hybridisation Sensor   
   ͣ Potential applicability for point-of-care: † Low; ††Moderate; ††† High 
 
2.4.3.  Mechanical Detection Based Devices 
 
Mechanical detectors comprise of mass sensitive sensors which rely on surface acoustic waves and 
effects first described in 1880 as piezoelectric[112]. The phenomenon of piezoelectricity is the ability 
of some crystalline and ceramic materials to generate an electric potential when subjected to stress. 
Physics laws dictate that rigid solid objects inherently resonate at certain frequencies and these 
frequencies can be shifted by incorporating an additional mass. Through some mathematical 
manipulation of this frequency one can determine the linked change in mass[113]. 
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2.4.3.1. Quartz Crystal Microbalance (QCM) Based Devices 
 
This instrument operates on a piezoelectric quartz crystal that can be manipulated to vibrate at elevated 
frequencies by an influence of an electric current thereby allowing for frequency based determination 
of biomolecular masses. The QCM can be easily converted into a biosensor by immobilizing a receptor 
on the quartz crystal surface. The subsequent binding/hybridization of the ligand molecule will register 
a change in the frequency of resonation[113]. An example of QCM application is where DNA 
hybridization processes have been studied with enough selectivity that discriminated complimentary 
and non-complimentary DNA strands using capture probe DNA immobilised on quartz crystal. This has 
been applied for end point detection and analysis of PCR products[114, 115]. Although a few 
researchers have reported success in the detection of multiplexed reactions, complexity of multiplexing 
still remains a major challenge with QCM popularity. However, the main drawback of the technique is 
that dry conditions are still a necessity with this technique; this implies that after receptor-ligand 
hybridisation, accurate measurements are still dependent on drying the QCM since liquid media cause 
a significant vibrational damping. Most bioanalytical approaches depend on liquid phase analysis 
therefore this renders the QCM applicable to limited cases[116]. Uludag and Tothill described their 
development of a point-of-care immuno-sensor that detects a cancer biomarker (total prostate-specific 
antigen, tPSA) using a quartz crystal microbalance (QCM) sensor platform in human serum samples. 
They performed a sandwich assay using antibody-modified gold nanoparticles [117]. García-Martinez 
and team used a 50 MHz quartz crystal microbalance (QCM) to detect DNA target concentrations higher 
than 50 ng/mL with resolution of 7.1 ng/cm2 [118]. Xia and team developed a rapid piezoelectric quartz 
crystal microbalance (QCM) based nucleic acid biosensor using gold nanoparticles for detecting S. 
epidermidis in clinical specimens [119]. Table 2.10 (below) summarises some of the microfluidic work 
in which quartz crystal microbalance (CQM) detection was applied. 
Table 2.10 |Summary of Devices Based on Quartz Crystal Microbalance (CQM) Principle of 
Mechanical Detection. 




interest Assay Technology Duration at POC   ͣ
Prostate Sandwich QCM _ _ 
†† 
[117] 
Cancer Antigen Immunoassay Sensor  
DNA 
DNA QCM _ 
~50 ng/mL † 
[118] 
Hybridisation Sensor  




epidermidis Hybridisation Sensor   
   ͣ Potential applicability for point-of-care: † Low; ††Moderate; ††† High 
2.4.3.2. Cantilever-Based Detection Based Devices 
 
These systems have a miniaturised cantilever and are better alternatives to QCMs. These cantilevers 
that are usually made from ceramics or crystalline materials, rely on piezoelectric principles. The 
 
  School of LM & MS                                           34                                                        University of KwaZulu-Natal 
 
measurements are derived from monitoring the deflection of a laser beam away from the tip of the 
cantilever. The readings are similar to QCM because they are translated from resonant frequency shifts 
as a result of ligand binding to the immobilized receptors. Literature suggests that this method has been 
used to sensitively detect single-base DNA mismatches and differentiating complementary and non-
complementary DNA sequences[120]. The major drawback of the cantilever approach is its reliance on 
expensive laser systems for signal detection. Zhou and team reported the piezoresistive detection of p53 
antibody, a biomarker for early-stage cancer diagnosis using a microcantilever biosensor with a 20 
ng/ml limit of detection. In their work, they performed an on-surface immobilization of the probe to 
detect p53 antibody and measured the deflection of the microcantilever using integrated piezoresistors 
[121].  Hansen and team demonstrated the discrimination of DNA mismatches using a microcantilever-
based optical deflection assay, without the need for external labelling. This work holds potential to 
characterize single-nucleotide polymorphisms (SNPs) which have become a major current focus in 
genomic research [122]. Table 2.11 (below) summarises some of the work in which the microcantilever 
detection principle was applied in microfluidics. 
Table 2.11 |Summary of Devices Based on Microcantilever Principle of Mechanical Detection. 




interest Assay Technology Duration at POC   ͣ
p53 Cancer Recognition Microcantilever _ 
20 ng/ml † 
[121] 
Antibody Immunoassay Bioensor   
DNA SNPs 
Probe-DNA Microcantilever _ _ 
† 
[122] 
Hybridisation Biosensor    
   ͣ Potential applicability for point-of-care: † Low; ††Moderate; ††† High 
2.4.4.   Thermal Detection Based Devices  
 
From a thermodynamics standpoint, thermal methods detect characteristics of materials or chemical 
reactions by measuring the internal energy present in any state of the system’s thermodynamic 
equilibrium by virtue of its temperature. The combination of thermal measurement techniques and 
microfluidic systems has allowed the feasibility of capturing different bioanalytical measurements with 
efficiency because of the associated low reagent consumption, high heating efficiency as well as 
minimized measurement time. Thermal measurement approaches can be categorised into thermal 
particle detection and calorimetry[123, 124]. 
 
2.4.4.1. Thermal Particle Detection (TPD) Based Devices 
 
This technology uses heat transfer to detect and count particles in relation to their size. Thermal particle 
detection has attracted a considerable attention from researchers in microfluidics as they seek to find 
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detection applications for industrial, environmental and biological analysis [125]. TPD in contrast to 
most methods, complex optical, complex electrical set ups as well as complicated signal mathematical 
manipulation are minimised. The major limitation of this method is that it requires excessive insulation 
which might turn costly [124]. Vutha and colleagues recently demonstrated their employment of heat 
to quantify microscopic particles using a thermal particle detector (TPD). They were able to resolve 
particles with diameters of 90 and 200 µm as having relative temperature changes of 0.11 and-0.44 K, 
respectively, in their continuous flow sensor [126]. 
2.4.4.2. Micro-Calorimeter Inspired Thermal Characterisation Based Devices 
 
This approach harnesses thermal conductivity and specific heat measurements to characterise materials 
using an on-chip calorimetric device. Some of the advantages of doing calorimetry at microscale in 
contrast to macroscale are that, reagent consumption is greatly reduced and automation results in 
increased precision and repeatability. Esfandyarpour and Davis developed an on-chip- integrated 
microfluidic calorimeter coupled to an on-chip sequential injector and multiplexing module. This device 
characterizes heat of reaction with 2-nW resolution strength in the nanoliter realm. These researchers 
were able to do real-time on-chip DNA “thermosequencing”[127]. Table 2.12 (below) summarises 
some of the work on thermal detection based microfluidic devices. 
  
Table 2.12 |Summary of Devices Based on Thermal Particle Detection (TPD) and Micro-Calorimeter 
Principles of Mechanical Detection. 




interest Assay Technology Duration at POC   ͣ
Microscopic Resistive Change Thermal Paticle _ _ 
† 
[126] 
Particles in Temperature Detector   
DNA SNPs Thermosequensing 
Micro- _ 
2 nW RMS † 
[127] 
Calorimetry   
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2.5. Knowledge Gaps 
 
Our literature findings in previous sections suggest that conventional TB diagnosis continues to rely 
on tests such as smear microscopy and culture methods despite them having known limitations. 
Efforts to develop tests for detection of drug resistance has yielded alternatives that are slow, costly, 
tedious and difficult to apply in field conditions. However, with recent advances in detection 
methods and emerging biosensor technologies, the diagnosis of active TB disease, and detection of 
drug resistance can be soon realised. We hereby propose new diagnostic tools that include newer 
versions of nucleic acid amplification tests for detection TB drug resistance conferring mutations. 
Although an ideal test for TB has not yet been created, considerable progress has been made over 
the past decade. This captured our interest in the development of a new tool for TB control with 
tangible benefits enabling it to reach the populations in developing countries that need cheaper 
diagnostic services the most.  
Heterogeneity in TB lesions is also not well understood because of the limitations (stated in previous 
section) with current diagnostic tools. Lenaerts and her research team attributed the heterogeneity 
in TB to its lesions being complex and extremely dynamic microenvironments. Their research 
further suggests that the immunopathological diversity of cavities and granulomas creates a plethora 
of microenvironments that force M. tuberculosis bacilli to adapt. This ultimately affects processes 
such as metabolism, DNA replication and relatively the density of microbial subpopulation. All 
these factors subsequently lead to respective susceptibility or resistance to chemotherapeutic 








3.  Microfabricated Devices for Detecting Mutants Using PCR & 
HRMA 
 
3.1. Research Aims and Objectives 
3.1.1. Research Aims 
To harness to our advantage, the underlying principles of microfluidics through developing a cost 
effective, highly scalable platform—for fluorescence based genomic interrogation of Mycobacterium 
tuberculosis clinical isolates using real-time PCR and HRMA.  
 
3.1.2. Research Objectives 
1. To build a highly scalable, affordable, label-free-automated-microfluidic, fluorescence-based; 
real-time nucleic acid amplification and high resolution melt analysis (HRMA) system. 
2. To demonstrate as a proof of principle, its potential to detect tuberculosis and rifampicin 
resistance based on DNA melting temperature (Tm) with high accuracy, specificity and 
sensitivity 
3. To demonstrate as a proof of principle; the system’s potential to do single copy nucleic acid 
amplification (Digital PCR); and subsequent HRMA for application in the detection of 
heteroresistance and heterogeneity in clinical samples based on DNA melting temperature (Tm) 
with high accuracy, specificity and sensitivity. 
4. To design (in AutoCAD); fabricate (photolithography and soft lithography); and optimise PCR 
microfluidic devices. 
5. To write a Matlab program with a code that automatically computes meaningful conclusions 
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Table 3.1|Lithography Consumables 
Consumables Vendor/Reference Number 
3 – 4” Silicon wafers (Type P), 500µm thick WaferShipper 
5x5” glass plate(s) for UV exposure -- 
Acetone Sigma-Aldrich, St Louis, MO 63103, U.S.A 
Aluminium foil SAPPHIRE 
Compressed Air Gun --  
HMDS (hexamethyldisilzane) Micro Chemicals, St Louis, MO 63103, U.S.A 
ma-D 531 Developer Microresist technologies, Berlin, Germany 
MAP 1275 Photoresist Microresist technologies, Berlin, Germany 
PDMS GE 615 RTV (Part A) Momentive, Waterford, New York 12188, U.S.A 
PDMS GE 615 RTV (Part B) Momentive, Waterford, New York 12188, U.S.A 
Petri Dishes Falcon 
Photomasks Outputcity (CAD/Art Services, Inc. 541-347-5315 
Polyester Nanowoven Wipes  Amplitude Delta, Spartanburg, SC 29303, U.S.A 
SU-8 Developer Micro·Chem Corp, Newton, MA 02464, U.S.A 
SU-8 Photoresists Micro·Chem Corp, Newton, MA 02464, U.S.A 
TCMS Sigma-Aldrich, St Louis, MO 63103, U.S.A 
Tygon® Tubing AAD02103-CP 






Equipment Vendor/Reference number 
Contact Mask Aligner SÚSS MicroTech MJB4 
Flatbed Thermocycler G-Storm GS-1, Somerset TA117JH, UK 
Hard Baking Oven Thermoscientific 
Hot Plates Torrey Pines Scientific Inc, Carlsbad, U.S.A. 
Luca R EMCCD Camera Andor 
Microfluidic Chip/Mold Inspection Microscope Olympus BX51, Tokyo, Japan 
Mold Profilometer KLA Tncor D-120, Milpitas, California 95035 U.S.A. 
Olympus Alignment Light Source KL 1600 LED, Tokyo, Japan 
Olympus Alignment Light Source KL 1500 LCD, Tokyo, Japan 
PDMS Curing Oven Binder, USA 
PDMS Layer Alignment Microscope Olympus SZX16, Tokyo, Japan 
PDMS Mixer THINKY Corporation Japan, Model ARE-250 
PDMS punch Press SCHMIDT Technology Corp, Cranberry, Germany. 
Pull Vacuum Bell Jar Bell-Art Products 1-800-4BEL-ART 
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Rocker IKA ROCHER 3D digital 
Spin Coater 
Laurell Tech Corp (WS-650MZ-23NPP), North 
Wales 
Spin rinse dryer 
Laurell Tech Corp (WS-650MZ-23NPP), North 
Wales 
Stereo Macroscope Olympus MVX10, Tokyo, Japan 
Temperature Sensing Probe NI USB-TC01 National Instruments, U.S.A. 
Timers Capital Lab Supplies, Durban, South Africa 
UV Source X-cite 120PC, New York, U.S.A 






Software Providing Company 
AutoCAD 2013 Autodesk 
GraphPad Prism Version 6.03 GraphPad 
LabVIEW Student Version 2011(M7X44797) National Instruments 
MATLAB Student Version R2012a (7.14.079) MathWorks 
 
 
3.2.4. PCR and HRMA Reagents 
 
Table 3.4 | Reagents for RealTime PCR and HRMA Assays 
Reagent Supplier 
Buffer Novagen®, Merk 
dNTPs Novagen®, Merk 
LC Green Plus+ BioFire Diagnostics, Inc Salt Lake City, Utah U.S.A 
F Primer Inqaba Biotech, Pretoria, South Africa 
R Primer Inqaba Biotech, Pretoria, South Africa 
KOD Polymerase Extreme Hot Start DNA Polymerase Novagen®, MerK 
1% Tween 20 Sigma-Aldrich, St Louis, MO 63103, U.S.A 
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3.2.5. Characteristics of used clinical isolates 
 
Table 3.5 |Characteristics of the Clinical Isolates Used for Comparison with H37RVe 
 DR-Mutation(s) detected Mutation  Phenotypef 
 by Sanger Sequencing Class       
Isolates rpoB   RIF INH OFLX 
R 35 CTG → CCG 1 Resistant Resistant Susceptibleg 
  (L533P)         
KZN 605 GAC → GGC 1 Resistant Resistant Resistanth 
 (D516G)     
 CTG → CCG 1    
  (L533P)         
Tkk-01-062 GAC → GTC 4 Resistant Resistant Susceptiblei 







                                                          
e This sequencing data was jointly obtained with Ian Mbano from Inqaba Biotech 
f The phenotypes were determined by Dr Adrie Steyn’s and Dr Manormoney Pillay’s research groups 
g The phenotypes were determined by Dr Manormoney Pillay’s research group 
h The phenotypes were determined by Dr Manormoney Pillay’s research group 
i The phenotypes were determined by Dr Adrie Steyn’s research group 
 




3.3.1. AutoCAD photomask Design  
 
Microfluidic-Bioengineering is a science at the intersection of biology and engineering, therefore its 
design procedures are heavily borrowed from techniques that are routinely used in engineering and 
architecture. The photomasks for microfluidic devices’ fabrication were designed using the Autodesk 
AutoCAD software. This software is based on a hybridisation principle of command-line and 2D visual 
designing platforms. The designing process largely relied on the Stanford Microfluidic Foundry online 
guidelines (http://web.stanford.edu/group/foundry) that included: 
 Initiation to AutoCAD 
 Microfluidic chips basic designing rules 
 Rules for photomask designing 
 Basic Hitchhiker’s guide to AutoCAD[129]. 
3.3.2. AutoCAD Design Fundamentals 
 
Using the above-mentioned AutoCAD guidelines, the microfluidic device photomasks were designed 
with line based drawing tools that included lines, splines and polylines. However, for the purpose of 
conversion of the AutoCAD files (.dwg) into the format that is readable to a mask printer can read (.dxf), 
it was ensured that no open line segmentation existed in the drawings by employing the polyline tool. 
Figure 3.1 shows some illustration of how Jerome Rogich designed the Spider PCR microfluidic chip 
using the AutoCAD software. 
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Figure 3.1 AutoCAD design illustration of the Jerome Rogich spider design microfluidic chip. AutoCAD 
allowed the design of microfluidic devices’ photomasks. We employed line based drawing tools that 
included lines, splines and polylines shown on the window toolbar. However, for the purpose of 
conversion of the AutoCAD files (.dwg) into the format that is readable to a mask printer can read (.dxf), 
it was ensured that no open line segmentation existed in the drawings by employing the polyline tool on a 
complete design. 
 
3.3.3. Patterning and Layering 
 
Microfluidic designs consisted of some networked features that were repeat units, hence for maintaining 
precision and uniformity among similar features the “Array” tool was employed. These photomasks are 
characterised with regions of dark and light polarity. The “layering” tool was used to distinguish the 
regions of the mask that corresponded to the dark and light polarity on the AutoCAD design. 
 
3.3.4. Considering Dimensions  
 
3.3.4.1. Aspect Ratios and Feature Resolution Optimisation 
 
In pursuit of firm and stable microfluidic features, the general principle that most stable features adhere 
to staying within the bounds of a minimum aspect ratio 1:10 (height:width) and a maximum aspect ratio 
of 5:1 was followed. This implied that on requiring the PCR chambers to have a height of 200 µm while 
retaining their stability/firmness without supporting features, the minimum and maximum width for the 
 
  School of LM & MS                                           43                                                        University of KwaZulu-Natal 
 
flow photomask design was to be 20 µm and 1000 µm respectively. The Figure 3.2 (below) illustrates 
how the aspect ratios were put into account for feature resolution in the designs. 
 
 
Figure 3.2| Illustration of the putting into account of aspect ratios. (A) Examples of levels of difficulty 
associated with fabricating features of various aspect ratios with photolithography and soft lithography. 
Ideal aspect ratios are 1:10 < 𝑥 < 5:1 (B) Illustration that aspect ratios are also crucial in gap features. 
Considerations were made in the photomask design such that the distance that resulted between SU-8 
features was not too small, by this, avoidance of fusion at unintended locations due to UV diffraction 
during exposure and curing processes was ensured. 
The design of inlet and output ports was done in a manner allowing fluids from a source into the device. 
Dimensional consideration of hollow stainless steel pins and Tygon® tubing to be employed were taken 
into account in relation to the size of the corresponding ports. 
Completed photomask designs were shipped to Outputcity (CAD/Art Services, Inc. 541-347-5315 
www.outputcity.com) for printing on flexible, inexpensive plastic films that generally guarantee feature 
resolution ranging between 5 and 10 µm. Before each photomask print a digital PDF format proof of 
each pattern was provided by Outputcity for re-inspection of design features ensuring all lines were 
polylines, no line gaps and no stray construction lines. The final photomask transparencies consisted of 
dark regions that corresponded to the “opaque” regions. 
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3.4. Microfabrication Process 
 
At this stage the guidelines for microfluidic device master fabrication using photo lithography were 
used. The determination of each feature’s desired height through optimising the parameters that included 
pre-baking time, post-baking time, exposure time, spin coating speed, choice of photoresist viscosity 
and developing time was done. Recommendations for some specifications on commonly used feature 
heights were sourced from MicroChem (website| http://www.microchem.com/) and in some instances 
when the desired height was not available among the recommendations, adjustments were made to the 
spin coating speed/acceleration, exposure time and photoresist choice. 
 
3.4.1. Mold Fabrication:  
 
3.4.1.1. Flow Mold  
 
The 3’ or 4’ wafers had their surface first primed with HDMS (adhesion promoter) vapour for 1 min in 
a plastic container at standard room temperature and pressure (STP). The wafer was then placed and 
held by vacuum power on a Laurell technologies corporation (model WS-650MZ-23NPP) spin coater 
stage. After dispensing the photoresist of desired viscosity, the wafer was spun at a specified (rpm) 
speed and acceleration for a specified time that ensured desired photoresist film thicknesses. Soft contact 
baking on a hotplate at specified temperature and duration followed. Soon after soft bake, it was ensured 
that the photoresist was fully dry. The wafer were UV-exposed by a mask alignerfor a specified duration 
with a photomask in contact with it from the top to ensure photoresist curing in a manner defining the 
channel structures. The wafer was then developed in developing solution, rinsed with deionised H2O 
and dried under house clean dry air. A hard baking step involving placing the mold in the oven and 
ramping the temperature from 120 °C to 180 °C, then held for 1 hr after which the oven was reversely 
ramped from 180 °C to 120 °C followed. This completed the first layer of the mold. However, in 
instances where the flow mold required was a hybrid, then a second layer of photoresist of desired 
viscosity was spun at a specified (rpm) speed and acceleration for a specified time in relation to the 
envisioned photoresist film thickness. Pre-exposure contact baking was performed using a hotplate at 
specified durations and temperatures (5 min x 65 °C / 20 min x 95 °C). The wafer was exposed to UV 
after the alignment of the mask of the subsequent top layer. This alignment was done in correspondence 
to the bottom layer with the aid of design alignment marks and a contact mask aligner (SÚSS MicroTech 
MJB4). The desired microwells were defined by the curing of UV-exposed regions of the mold. The 
exposed mold was subjected to post-exposure baking (1 min x 65 °C / 12 min x 95 °C / 1 min x 65 °C) 
and cooled to room temperature. For the fabrication of rounded channelled masters, the photoresist 
coated wafers were left at room temperature overnight and then baked by contact on a hotplate at 115 
 
  School of LM & MS                                           45                                                        University of KwaZulu-Natal 
 
°C for 15 min. The final development was done in a developing solution for 5 min and rinsed with fresh 
developer solution and dried under house clean dry air. (See Appendices A for each mold design 
specifics) 
3.4.1.2. Control Mold Fabrication 
 
For all control molds, the wafer was placed and held by vacuum power on a spin coater (Laurell Tech 
Corp (WS-650MZ-23NPP), North Wales) stage. After SU8 2025 photoresist was dispensed, the wafer 
was spun at 3000 rpm for 1 min using an acceleration of 133 rpm-2 to attain film thicknesses of 25 
microns on average. Pre-exposure contact baking followed using a hotplate (1 min at 65 °C / 5 min at 
95 °C) and the wafer was then cooled to room temperature. The wafer was then exposed to UV-light 
through the control photomask for 15s to define control structures. Post-exposure bake (1 min at 65 °C 
/ 5 min at 95 °C) followed. The wafers were then cooled to room temperature after which they were 
developed using developer solution for 5 minutes, rinsed with fresh developer solution and dried under 
house clean dry air. Final hard bake was carried out by contact hotplate (150 °C x 60 min). (See 
Appendices A for each mold design specifics).  
3.4.2. Soft Lithography Process 
 
All molds that resulted from above sections were subjected to trimethylchlorosilane (TMCS) vapor for 
1 min in a plastic container at STP.  
3.4.2.1. Flow Layer 
 
For flow layer casting, the combination in 5:1 GE 615 RTV (A: B) of total amount in relation to the 
desired flow layer thickness was done. A hybrid mixer (THINKY Corporation Japan, Model ARE-250) 
was used for mixing with 5 min mixing time and 5 min degassing time. An amount of the mix in 
proportion to the desired thickness of the flow layer was poured onto the flow mold (petri dish lined 
with Aluminium foil). The flow layer was degassed via pull vacuum in bell jar (Bell-Art Products 1-
800-4BEL-ART) --for approximately 30 minutes) and the residual bubbles were manually popped with 
an L-shaped spreader.  The curing step of the flow layer was done by baking the wafer in a convection 
oven set at 80 °C for 40 min. 
3.4.2.2. Control Layer:  
 
The combined in 20:1 GE 615 RTV (40 g A: 2 g B) was mixed using a hybrid mixer set at 5 min mixing 
time and 5 min degassing time. A portion of 5 mL of the mixture was then dispensed on the control 
layer mold and spun it at 1800 rpm for 60 s at an acceleration of 500 rpm-2 to generate a film thickness 
of 25 microns. Curing of the control layer was done by baking in convection oven set at 80 °C for 40 
min. 
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3.4.2.3. Dummy Layers:  
 
The remaining 5 mL of 20:1 GE 615 RTV (40 g A: 2 g B) mix was spun (using a spin coater Laurell 
Tech Corp (WS-650MZ-23NPP), North Wales) on a blank wafer at 1800 rpm for 60 s at an acceleration 
of 500 rpm-2 generating a film thickness of 25 microns. Curing of the dummy layer was done by baking 
in convection oven set at 80 °C for 40 min.  
3.4.2.4. Control/Flow Bonding 
 
The flow layer was peeled off from the mold and the flow inlet and outlet ports were punched with a 
punch press. Thereafter, the punched flow layer was aligned (using Olumpus SZX16, Tokyo, Japan) to 
the control layer (still on the mold). The baking of the resulting hybrid was done in a convection oven 
at 80 °C for 40 min. After allowing the bonded hybrid device to cool to room temperature, cutting 
around the periphery of the thick layer and peeling of the hybrid device off the control layer mold as 
well as punching control inlet ports was done. 
3.4.2.5. Flow/Control/Dummy Bonding 
 
Finally, the control/flow hybrid structure was placed on the dummy layer bound to a blank wafer and it 
was ensured that there were no air bubbles and no collapsed valves/ control channels. The resulting 
device was baked in a convection oven (Binder, USA) at 80 °C for 8 hours. The final quality control of 
the device was done though inspection for air bubbles, linen, collapsed channels etc. This was done 
under a microscope (Olympus BX51, Tokyo, Japan) and became ready for use. 
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3.4.3. The LightForge System Set-Up 
 
The Real-Time PCR and High Resolution Melt Analysis (HRMA) were done on a system that we 
developed in-house called The LightForge System which has the potential of bringing a new era to lab 
on a chip technologies. LightForge driver is built on a LabView (from National Instruments, USA) 
program that runs on a temperature feedback loop. Figure 3.3 shows a schematic flow illustration of 
how the LightForge system operates. A microfluidic chip is installed with its base in contact with the 
flatbed of the thermocycler—(G-Storm GS-1, Somerset TA117JH, UK). A temperature sensing probe—
National Instruments was also installed at the base of the microfluidic chip wired to a computer. PCR 
master mixes are pressure driven at 5 psi into the reactor chambers via Tygon® tubing. Each chamber 
is sealed via on-chip elastomeric control line valve closures as instructed by the LightForge computer 
program throughout the duration of PCR and HRMA. At each low temperature PCR cycle step, the 
computer program instructs the shutter mounted on the Olympus MVX10 stereo macroscope to open. 
This allows the chip to be excited by the UV light(x-cite) and simultaneously instructing the Luca R 
EMCCD Andor camera to take real-time images. The MATLAB script embedded into the LightForge 
(LabVIEW) program at the same time proportionally computes the pixels on each image in relation to 
the fluorescence signal. This is because as the PCR products accumulate, the relative fluorescence units 
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Figure 3.3| Schematic illustration of how The LightForge system works. The scheme shows the 
experimental setup used in this work. Individual reaction chambers of the chip are loaded with PCR 
specified PCR master mixes; microvials in red are replicates of the clinical isolate under study; 
microvials in blue are replicates of the reference H37RV standard; microvials in gray are the non-
template control replicates; in green is the control line controlling opening and closure of valves on the 
chip with instructions from the LightForge computer program. The chip is connected to the temperature 
probe that send feedback to the LightForge computer program. This temperature feedback instructs the 
shutter to open at desired temperature allowing the CCD camera to capture a fluorescent image via a 
stereo macroscope. Images after every cycle are captured in real-time and the real-time PCR and HRMA 
data displayed on the computer screen after automated Matlab image processing.i 
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3.4.3.1. Matlab Image Processing 
 
The LightForge System captures Real-Time PCR and High Resolution Melting images and processes 
them by generating arrays of pixel values that are proportional to the fluorescence brightness of the 
reactors. We then used a Student Version MATLAB®2012a software from MathWorks® (See 
Appendix C for the developed code) to translate this enormous pixel data into curves deducing the 
Real-Time PCR Amplification curves (Relative Fluorescence Units (RFUs) vs PCR Cycle Number), 
High Resolution Melt Analysis curves (Relative Fluorescence Units (RFUs) vs Temperature), 1st 
Derivative Melt Peaks ((–dRFUs/dt) vs Temperature). 
3.4.3.2. Polymerase Chain Reaction (PCR) and High Resolution Melt Analysis 
(HRMA) Primer Design 
 
As shown in Table 3.6 (below)[130], we designed two pairs of primers for real-time PCR to amplify 
the rpoB and gyrA (positive control), specifically targeting sites at which mutations associated with drug 
resistance are found, namely, for rpoB, the 81-bp RIF resistance determining region (RRDR); and for 
gyrA, a region including several resistance-associated sites (OFLX resistance). 
 
Table 3.6| PCR and HRMA Primer Design 
Primer Sequence 5'-3' 
Amplicon  Anealing Nucleotide GenBank 
Size (bp) 
Temp (°C) Locations 
accession 
no. 





rpoB-R TGACAGACCGCCGGGCCC 2456-2439 





gyrA-R GCTTCGGTGTACCTCATCG 2700-2682 
 
3.4.3.3. DNA Extraction 
 
Genomic DNA from M. tuberculosis- H37RV (reference susceptible lab strain) and clinical isolates of 
KZN 605, R35 and R271was extracted and provided by research groups of Drs Adrie Steyn and 
Manormoney Pillay from KwaZulu Natal Research institute for TB and HIV(K|RITH) and University 
of KwaZulu Natal(UKZN) respectively. 
 
3.4.3.4. Polymerase Chain Reaction (PCR) and High Resolution Melt Analysis 
(HRMA) 
The (On-Chip) bulk PCR mixture was prepared and optimised in relation to the (Off- Chip) commercial 
Roche LightCycler® 96 system requirements as shown in the Table 3.7.  
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Table 3.7| Used Optimised on-Chip PCR Master Mix Derived from off-Chip Master Mix 
Component 
On- Chip Master Mix Off-Chip Master Mix 
Volume Activity Volume Activity 
Buffer 37.5 0.5 25 0.5 
dNTPs 15 0.2 10 0.2 
LC Green 7.5 0.1 5 0.1 
F Primer 2.25 0.03 1.5 0.03 
R Primer 2.25 0.03 1.5 0.03 
KOD Polymerase 1.5 0.02 1 0.02 
1% Tween 20 6 0.06 _ _ 
PCR Grade Water _ _ 1 0.02 
Total Volume 75 1 50 1 
*~ 50 ng of DNA template 
PCR amplification was performed using the G-Storm GS1 flatbed thermal cycler (Somerset TA117JH, 
UK), with optimised initial denaturation at 97°C for 8 min, followed by 35 cycles of 98°C for 60 s, 60°C 
for 115 s, and 74.5°C for 130 s and a final elongation at 72°C for 10 min. A non-template control 
containing sterile distilled water was included in the experiment. 
For HRMA, we melted the PCR products from 75 to 95 °C with fluorescence data acquisition being 
carried out at regular increments—at 0.25 °C/step at a rate of 0.5 °C/sec—with specified holds at 
each step. The HRMA curves were analyzed using Student Version MATLAB®2012a software from 
MathWorks®. The melting temperatures of replicated clinical isolates’ plots were generated and 
compared to the wild-type (rifampicin susceptible H37RV) melting profile after normalizing the melting 










4.0. Temperature Conduction Optimisation 
 
Since PDMS is a poor conductor of heat, inorder for PCR to work on a chip, it is important for the 
PDMS microdevice to be placed on a base that has the ability to rapidly gain and rapidly lose heat. This 
facilitates the heating and cooling essential for PCR thermal cycling efficiency. 
4.0.1. Glass Substrate Base 
 
We conducted an experimental iteration to investigate the effect of attaching a glass base to the PDMS 
microfluidic device on a flatbed thermal cycler. This setup revealed that although glass is a cheaper 
material to work with in disposable POC devices, its thermal properties did not allow efficient heat 
transfer. The poor conducting nature of glass resulted in the 3 stage PCR reactions requiring longer time 
frames at each stage to allow the chip to attain the required temperature. 
4.0.2. Thinner Glass Substrate Base 
 
We hypothesised that the inefficient heating—from the iteration above—was probably as a result of the 
glass slide base being too thick, therefore we reduced the thickness of the glass and employed a thinner 
glass cover slip base. Despite improvement in the heating efficiency, the PCR duration was still very 
long and the cover slip proved to be delicate and largely affecting our yield of chips. 
4.0.3. Thermal Grease 
 
We then reached the hypothesis that the inefficient heating was probably as a result of lack of close 
contact between the glass bases and the flatbed of the thermal cycler. To test this hypothesis, we smeared 
a thin film of silicone heat transfer compound (Unick Chemical Corp) between the flatbed of the thermal 
cycler and the chip glass base. The heating efficiency improved slightly. However, the grease being a 
lubricant, it resulted in the lateral movement of the chip such that the regions of interest on the chip 
were out of their initial positions within a couple of PCR cycles. Therefore we concluded the use of 
thermal grease to be unfavourable. 
4.0.4. Polysilicon Substrate Base 
 
We then performed the final iteration of employing a silicon substrate as a base of the PDMS 
microfluidic device. As shown in Figure 4.1, the experimental results reveal that the LightForge 
temperature log profile from a polysilicon substrate base provided the most improved heating efficiency. 
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Figure 4.1A shows how the LightForge system can complete the entire real-time PCR coupled to 
HRMA within 3 ½ hrs. We can also see the high degree of reproducibility of temperature profile from 
one cycle to the other. Silicon being a semiconductor demonstrated a strong ability to gain and lose heat 
in a manner sufficient for reasonably long PCR experiments. Hence the use of a polysilicon substrate 
base fulfilled our need of achieving the desired heating and cooling conditions for PCR cycles. 
4.0.5. General Description of the LightForge System’s Temperature Kinetics. 
 
 We optimised our temperature measurement by a contact temperature sensor method to get an initial 
understanding of PCR kinetics in our microfluidic system. As can be seen on Figure 4.1, there is a hot 
start activation step that is about 10 mins long—this duration was seen to be long enough to dissociate 
the anti-thermococcus kodakaraenis—KOD-- DNA polymerase antibodies and/or accessory proteins 
that keep the polymerase inactive at lower pre-PCR temperatures. Depicted also by Figure 4.1 also, are 
the defined periodical repetitions of three different temperature zones—melting, annealing and 
extension zones. 
a. DNA melting temperature zone: this was the highest temperature attained in each periodic PCR 
cycle. This can be seen in Figure 4.1(B) to be just below 95 °C on average on this LightForge 
platform—congruous to the acceptable temperature range for DNA denaturation that is between 
90 and 95 °C. 
b. Primers’ annealing temperature zone: from Figure 4.1(B), this zone follows the melting 
temperature zone. Since this temperature is optimised for each primer pair because of its 
dependence on the nucleic acid sequence, we can see in Figure 4.1(B) that we optimised the 
annealing temperature to be around 60 °C. 
c. Primer extension temperature zone: as can be seen on Figure 4.1(B), this was the medium 
temperature zone that was averaging at 73 °C. 
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Figure 4.1|LightForge System PCR polysilicon base thermal profiling. A) Illustration of 35 PCR cycles 
and HRMA. B) Detailed thermal cycling conditions of the first 4 PCR cycles On Figure 4.1B; shown in 
detail are the steps performed by LightForge. Initially there is a denaturation step for the enzyme activaton. 
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Figure 4.2| Illustration of LightForge HRMA perfomance. shown above are the steps after the 35th PCR 
cycle; the temperature feedback loop program allows LightForge to enter a final extension step which is 
then followed by full a naturation step to ensure naturation of all PCR products. A full denaturation step 
follows later to eliminate primer dimers. The system is then lowered to a temperature sufficient for only 
PCR products excluding primer dimers to hybridize. It is only at this stage that the HRMA is initiated 
through ramping the temperature from 75 °C to 95 °C at 0.25°C/step at a ramp rate of 0.5 °C/sec. 
 
In Figure 4.2 (above), it can be seen that after the periodic repetitions of PCR cycles, there is a final 
extension step with a mean temperature around 73 °C for 8 mins. The system is then cooled down to 42 
°C for full DNA hybridisation. This low temperature of 42 °C signals the end of PCR periodic cycles 
and triggers the LightForge computer program to enter into a high resolution melt analysis (HRMA) 
phase. The initial step in this HRMA phase is the full denaturation of the PCR products at 92 °C for 2 
mins. The products are then cooled to a medium temperature of 75 °C where the temperature is ramped 
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At this stage we had a prototype system that could perform PCR in real-time as well as HRMA with 
periodic fluorescent image acquisition. We then hypothesised that:  
1. Can we do PCR in a microfluidic device that has19 nL reaction chamber volumes—2 632 times 
reaction volume reduction in comparison to current conventional PCR volumes which can be 
50 µL?  
To test this hypothesis we fabricated the microfluidic chip designed by Jerome Rogich shown in Figure 
4.3. Each of the reaction chambers in this chip have a 19 nL volume. The channels in red are 10 µm 
high. They are rounded channels and have a diameter of 200 µm. This makes each of the chambers 
shown in yellow in Figure 4.3(B) to have a volume of 19 nL as the height of each yellow chamber is 
190 µM. The chambers are sealed by pressurised elastomeric valves in the green layer of the 
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4.1. Jerome Rogich Spider Design Chip 
 
This chip was designed to test the possibility of conducting PCR on a Microfluidic chip. Figure 4.3 
(below) shows the AutoCAD complete design of the chip with 20 PCR reaction chambers(in yellow) 
independent of one another. Each chamber has its own input therefore 20 independent PCR experiments 
can be conducted on this chip. The total  volume of each reactor is 19 nL. 
 
Figure 4.3| Representation of Jerome Chip Fabrication. (A) The rounded first flow layer that has a height 
of 11 microns, consists of channels providing pathway to the reactors, the circular features are the inlet 
ports of the chip. (B) The hybrid structure that resulted from layering the 190 microns high PCR reaction 
chambers (the yellow layer) on top of A thereby yielding a complete Flow Layer mold; (C) shows the 23 
microns high Control mold monolayer that seals each of the PCR chambers in an elastomeric valve 
fashion; (D) is the complete Spider Design Chip showing how the aligned three layers function in 
conjunction with one another.j  
 
                                                          
j Designed by Jerome Rogich and fabricated by Tawanda Mandizvo 
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The chips produced from soft-lithography and photolithography processes were plugged into the 
LightForge system and loaded with PCR reaction mixtures. The automated sensing of temperature and 
real-time imaging allowed for twenty PCR experiments to be executed without the need for user 
intervention. As shown in Figure 4.4 experimental layout below, in each of the 20 PCR reaction 
chambers a unique real-time PCR progression signal was produced. Using LightForge, a custom 
software developed in-house in LabView (National Instruments) we controlled image acquisition and 
data processing. 
4.1.1. Experimental Layout 
 
 
Figure 4.4| Spider design chip Real-Time monitoring of PCR progression using the LightForge System. 
(A) Raw image taken by LightForge after the 1st PCR cycle at 60 °C. (B) Raw image taken by LightForge 
after the 35th PCR cycle 60 °C. (C) Matlab processed image taken by LightForge after the 35th PCR cycle 
60 °C. A and B show raw images that the lightForge system captured, with relatively low fluorescence 
intensity was observed at the beginning of the experiment (A --1st PCR cycle). As the PCR experiment 
progressed towards the 35th cycle (B) the fluorescence intensity signal got relatively stronger; (C) shows 
that by lowering the background signal, the reactors’ fluorescence intensity became even more 
pronounced. The reactors (4th row 1st and last columns) that harboured the non-template control maintained 
relatively weaker fluorescence signal even up to the 35th PCR cycle.k 
 
We successfully conducted PCR and HRMA using this microfluidic chip. Figure 4.4 (above) shows 
how we organised our PCR/HRMA experiments. A fluorescent double stranded DNA saturating dye 
LC Green was used to monitor the experimental progression. A fluorescent image was being acquired 
in real-time after every PCR cycle. However, in Figure 4.4, we only show the images of the 1st and the 
                                                          
k This data was jointly obtained with Ian Mbano, with whom I worked with on some aspects of the project 
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35th PCR cycles. The summary of overall observation from Figure 4.4 is that the fluorescence intensity 
of the 20 PCR reactions gradually get stronger as the cycle number increases—which is in consistent 
with the theoretical accumulation of PCR products. The HRMA was also conducted successfully after 
every 35th PCR cycle to determine the thermal properties of our PCR products. 
Since we could conduct PCR and HRMA on a microfluidic chip, we were prompted again to ask the 
following questions: 
a.  Is the LightForge system able to interrogate Mtb clinical isolates for the presence of drug resistance 
conferring mutations (SNPs)? 
b. Can we tally a high resolution melting temperature (Tm) or a melting curve profile to a specific 
clinical Mtb isolate—so that we can predict drug resistance? 
We attempted to answer these questions with the LightForge system using: 
1.  The genomic material from R35 multidrug resistant (MDR) clinical isolate. This clinical strain is 
known to have rifampicin resistance associated with a class 1 SNP mutation within its rpoB 
region—a rifampicin resistance determining region (RRDR). 
2. The genomic material from KZN 605 extensively drug resistant (XDR) clinical isolate. This strain 
was first isolated in Tugella Ferry in KwaZulu Natal province of South Africa. KZN 605 is known 
to have rifampicin resistance associated with two class 1 SNP mutations within its rpoB region—
a rifampicin resistance determining region (RRDR).  
3. The genomic material from Tkk 062 multidrug resistant (MDR) clinical isolate. This clinical strain 
is known to have rifampicin resistance associated with a class 4 SNP mutation within its rpoB 
region—a rifampicin resistance determining region (RRDR).  
The data for the R35 clinical isolate is shown in Figure 4.5. As can be seen (A) shows the real-time 
PCR amplification curves that are similar to those observed in conventional PCR commercial systems. 
Detectable levels of PCR products were registered after the 15th cycle. Shown in red are replicates for 
the R35 strain. In blue are the replicates for the standard H37RV reference strain. In black are the non-
template control replicates. The normalised HRMA data shown in (B) reveal the differences in the 
thermal properties of the PCR products of each loaded sample. Computing the –dRFU/dt in (C) it can 
be seen that all the three sample types gave distinct peak signatures. As theoretically expected, the R35 
isolate with a cytosine residue SNP substitute (CCG) had a higher melting peak temperature (Tm ~86.3 
°C); in comparison to the (CTG) for the reference strain H37RV (Tm ~83.9 °C). The non-template 
control in black had a broad peak signature with its –dRFU/dt maximum value at ~81 °C. The figure 
(D) shows the independence of the melt peak temperature to the fluorescence intensity—the melt peak 
temperature is related to the clinical isolate identity and not the intensity of the fluorescence in each 
PCR reaction chamber. 
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Shown in Figure 4.6 is the data for the KZN 605 clinical isolate. As can be seen (A) shows the real-
time PCR amplification curves that are similar to those observed in conventional PCR commercial 
systems. Detectable levels of PCR products were registered after the 15th cycle. Shown in red are 
replicates for the KZN 605 strain. In blue are the replicates for the standard H37RV reference strain. 
In black are the non-template control replicates that amplified around the 25th PCR cycle. The 
normalised HRMA data shown in (B) reveal the differences in the thermal properties of the PCR 
products of each loaded sample. Computing the –dRFU/dt in (C) it can be seen that all the three sample 
types gave distinct peak signatures. As theoretically expected, the KZN 605 isolate with cytosine 
residue and guanine residue SNP substitutes—(CCG) and (GGC)—had a higher melting peak 
temperature (Tm ~83.0 °C); in comparison to the—(CTG) and (GAC)—respectively for the reference 
strain H37RV (Tm ~82.0 °C). Despite KZN 605 having two class 1 SNPs, it was surprising to it having 
a smaller relative temperature difference in comparison to R35 which has one class 1 SNP. The non-
template control in black had no amplicon domain peak signature, with its –dRFU/dt remaining flat in 
the studied high resolution melting region. The figure (D) shows the independence of the melt peak 
temperature to the fluorescence intensity—the melt peak temperature is related to the clinical isolate 
identity and not the intensity of the fluorescence in each PCR reaction chamber. 
The data for the Tkk 062 clinical isolate is shown in Figure 4.7. As can be seen (A) shows the real-time 
PCR amplification curves that are similar to those observed in conventional PCR commercial systems. 
Shown in red are replicates for the Tkk 062 strain. In blue are the replicates for the standard H37RV 
reference strain. Also introduced in green are the H37RV gyrA positive control replicates. In black are 
the non-template control replicates. The normalised HRMA data shown in (B) reveal the differences in 
the thermal properties of the PCR products of each loaded sample. Computing the –dRFU/dt in (C) it 
can be seen that all the three sample types gave distinct peak signatures. As theoretically expected for 
a class 4 mutation, the Tkk 062 isolate with an adenine SNP substitute (GTC) had a closely similar 
melting peak temperature (Tm ~82.5 °C); in comparison to the (GAC) for the reference strain H37RV 
(Tm ~82.3 °C). The non-template control in black had no amplicon domain peak signature, with its –
dRFU/dt remaining flat in the studied high resolution melting region. As also expected the gyrA 
positive control had its own unique peak signature (Tm ~85.4 °C). The figure (D) shows the 
independence of the melt peak temperature to the fluorescence intensity—the melt peak temperature is 
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4.1.2. Interrogation of R35 Clinical Isolate 
 
  
Figure 4.5| Real-Time PCR and High Resolution Melt Analysis data for a rifampicin resistant MTB 
clinical isolate R35.ii (R35 = 7 in Red replicates) relative to a rifampicin susceptible (H37RV = 8 in Blue 
replicates). The (3 black replicates) are the non-template controls NTC. (A) The realtime amplification 
curves for 35 PCR cycles (B) Normalised High Resolution Melt Analysis curves ranging from 75 – 95 
°C. (C) The 1st derivative melt plots of the Normalised High Resolution Melt Analysis curves ranging 
from 75 – 95 °C. (D) Melting temperature peak in relation to maximum fluorescence intensity data 
display. From (A) it can be seen how the detectable concentrations of PCR products were achieved after 
15 cycles and it can be confirmed that the PCR experiment proceeded to saturation. The NTCs amplified 
after the 20th cycle. In (B) there is a distinction between the HRMA signatures of H37RV and R35. (C) 
show the profound differences from the 1st Derivative melt plot (-dRFU/dt vs temperature); (D) shows 
that H37RV had an average melting temperature (max –dRFU/dt) of 83.90813314 °C while R35 had an 
average melting temperature max (–dRFU/dt) of around 86.2908122°C. Although the NTCs amplified, 
their melt temperature signature was localised and distinct in relation to the sample signatures. b 
b This data was jointly obtained with Ian Mbano, with whom I worked with on some aspects of the project 
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Figure 4.6| Real-Time PCR and High Resolution Melt Analysis data for a rifampicin resistant MTB 
clinical isolate KZN 605(KZN 605 = 8 replicates in Red) relative to a rifampicin susceptible (H37RV 
= 8 replicates in Blue). In (black) is the non-template control NTC. (A) The real-time amplification 
curves for 35 PCR cycles (B) Normalised High Resolution Melt Analysis curves ranging from 75 – 95 
°C. (C) The 1st derivative melt plots of the Normalised High Resolution Melt Analysis curves ranging 
from 75 – 95 °C. (D) Melting temperature peak in relation to maximum fluorescence intensity data 
display. From (A) it can be seen how the detectable concentrations of PCR products were achieved 
after 16 cycles and it can be confirmed the PCR experiment proceeded to saturation. The NTCs 
amplified after the 24th cycle. In (B) there is a slight distinction between the HRMA signatures of 
H37RV and KZN 605; (C) shows the exacerbated differences from the 1st Derivative melt plot (-
dRFU/dt vs temperature); (D) shows that H37RV had an average melting temperature max (–dRFU/dt) 
of 82.01705253 °C while KZN 605 had an average melting temperature max (–dRFU/dt) of around 
82.96774752 °C. Though the NTCs amplified, their melt peak signature was not registered according 
to (C).iii 
 
c This data was jointly obtained with Ian Mbano, with whom I worked with on some aspects of the project 
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4.1.4. Interrogation of TKK-062 Clinical Isolate 
 
  
Figure 4.7| Real-Time PCR and High Resolution Melt Analysis data for a rifampicin resistant MTB 
clinical isolate TKK 062(TKK 062 = 8 replicates in Red) relative to a rifampicin susceptible (H37RV = 
8 replicates in Blue). In (black) is the non-template control (NTC). The two replicates in green are the 
gyrA positive controls from the H37RV genome. (A) The realtime amplification curves for 35 PCR cycles 
(B) Normalised High Resolution Melt Analysis curves ranging from 75 – 95 °C. (C) The 1st derivative 
melt plots of the Normalised High Resolution Melt Analysis curves ranging from 75 – 95 °C. (D) Melting 
temperature peak in relation to maximum fluorescence intensity data display. From (A) (above) it can be 
seen how the detectable concentrations of PCR products were achieved after 15 cycles and it can be 
confirmed that the PCR experiment proceeded to saturation. In (B) there is a slight distinction between 
the HRMA signatures of H37RV and Tkk -01-062; (C) shows the exacerbated differences from the 1st 
Derivative melt plot (-dRFU/dt vs temperature); (D) shows that H37RV had an average melting 
temperature max (–dRFU/dt) of 82.30025716 °C while Tkk -01-062 had an average melting temperature 
max (–dRFU/dt) of around 82.53506398 °C. Though one of the NTCs amplified after the 26th cycle, there 
was no melt peak signature according to (C). In this assay we also incorporated the positive control where 
we amplified (gyrA, green) a different region of the MTB genome. As expected the peak for gyrA was 
distinctly positioned at about 85.4 °C.iv 
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4.1.5. Summary of the Clinical Isolates Data 
 
Table 4.1| Summary of Strain HRMA Assays Data in Relation to H37RV 
 
DR-Mutation(s) 
detected Mutation  HRMA data 
 
by Sanger 
Sequencing Class       
Isolates rpoB   
Mean H37RV  
Tm (°C) 
Mean Isolate  
Tm (°C) 
Relative 
Difference  to 
H37RV Tm (°C) 
R 35 CTG → CCG 1 83.90813314 86.2908122 2.382679057 
  (L533P)         
KZN 
605 GAC → GGC 1 82.01705253 82.96774752 0.950694994 
 (D516G)     
 CTG → CCG 1    
  (L533P)         
Tkk-01-
062 GAC → GTC 4 82.30025716 82.53506398 0.234806817 
  D516V         
 
Table 4.1 above summarises the data from figures 4.5, 4.6 and 4.7. For the R35 clinical isolate that was 
described as resistant to rifampicin (RIF), isoniazid (INH) but susceptible to ofloxacin (OFLX) (See 
Table 3.5 in Materials and Methods Section Chapter 3); we focused on the rpoB region which had a 
class 1 mutation CTG → CCG (L533P). The mean melting temperature for R35 was 86.2908122 °C 
while that of the reference susceptible strain H37RV was 83.90813314 °C; owing to a 2.382679057 °C 
relative difference between the two strains.  
The KZN 605 clinical isolate that was described as resistant to RIF, INH and OFLX (See Table 3.5 in 
Materials and Methods Chapter 3); we also focused on the rpoB region which had two class 1 mutations 
CTG → CCG (L533P) and GAC → GGC (D516G). The mean melting temperature for KZN 605 was 
82.96774752°C while that of the reference susceptible strain H37RV was 82.01705253 °C; owing to a 
0.950694994 °C relative difference between the two strains. 
The Tkk 062 clinical isolate that was described as resistant to RIF, INH but susceptible to OFLX (See 
Table 3.5 in Materials and Methods Chapter 3); we also focused on the rpoB region which had a class 
4 mutation GAC - GTC. The mean melting temperature for Tkk 062 was 82.53506398 °C while that of 
the reference susceptible strain H37RV was 82.30025716 °C; owing to a 0.234806817 °C relative 
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The results at this point showed that; PCR can be conducted on a LightForge platform for only 20 
reaction chambers on Jerome Rogich design chip. The findings further reveal that 19 nL reaction 
volume is sufficient for PCR on the lightForge platform. These outcomes prompted us to ask the 
following questions in a bid to save reagents and time: 
1.  Can the LightForge platform perform PCR simultaneously in 720 reactions chambers? 
2. Can the LightForge platform conduct PCR in 1.8 nL reaction volumes—10.6 times reduction in 
comparison to the Jerome Rogich chip? 
3. Can the LightForge platform achieve individual Mtb genome interrogation per chamber—digital 
PCR (dPCR)? 
We designed and fabricated the following microfluidic chips in an attempt to answer the above 
questions: 
a. The serpentine design dPCR chip: This is shown in Figure 4.8. We derived its name from the 
serpent fashion of its flow layer shown in red in Figure 4.8(B). The volume of each of the reaction 
chambers is1.8 nL. The chip has four quadrants with each quadrant having 180 reaction chambers. 
b. The web randomising design dPCR chip: This chip is shown in Figure 4.11. Its name is derived 
from the web/net interconnection fashion of PCR reaction chambers to allow random filling of the 
chambers. This design is shown in detailed in Figure 4.12(E). The volume of each of the reaction 
chambers is1.8 nL. The chip has four quadrants with each quadrant having 180 reaction chambers 
to make a total of 720 chambers. 
c. Dead ended design dPCR chip: This chip is shown in Figure 4.15. Its name is derived from the 
fact that each row of chambers have a dead end. The volume of each of the reaction chambers is1.8 
nL. The chip has four quadrants with each quadrant having 180 reaction chambers to make a total 
of 720 chambers. 
Through these iterations we used the reactor brightness patterns (in figures 4.10, 4.13 and 4.16) to 
identify the dead ended design dPCR chip as the best candidate for the for future dPCR experiments 
on a LightForge platform. The post PCR image showing fluid dynamics for the serpentine design dPCR 
chip in Figure 4.10 (C) reveal an undesirable effect that the DNA sample distribution favoured some 
rows at the expense of others. Another unfavourable outcome can be seen in the web randomising 
design dPCR chip’s post PCR images. This again can be seen in Figure 4.13(C) and 4.14 where it is 
revealed that there is confinement of the brighter reactors at the periphery of the studied quadrant. The 
bias can be seen in that, the reactors in the middle of the quadrant were of uniformly weaker intensity 
in comparison to the peripheral reactors. However, Figure 4.16(C) which shows the post PCR image 
for the dead ended design dPCR chip shows a random reaction chamber fluorescence that we would 
expect for a digital PCR experiment. This signifies the expected random positive and negative reaction 
occurrence. 
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4.2. Serpentine Design dPCR Chip 
 
 
Figure 4.8| Serpentine Design dPCR chip. (A) The rounded “serpentine “first flow layer that has a height 
of 13 microns, consists of channels linking PCR reaction chambers all the way to the outlets, the circular 
features are the inlet/outlet ports of the chip. (B) The hybrid structure that resulted from layering the 180 
microns high PCR reaction chambers (the yellow layer) on top of (A) thereby yielding a complete Flow 
Layer mold; (C) is the 23 microns high control mold monolayer consisting of valves that control the 
sequential flow of reagents; (D) is the complete Serpentine Design dPCR chip showing how the aligned 
three layers function in conjunction with one another. The Serpentine Design dPCR chip shown above 
has four identical quadrants. Each quadrant has four inlet ports and one outlet port. One of the inlet ports 
is for inputting PCR master mix while the extra three were meant for inputting surface pre-treatment 
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4.2.1. Zooming into Serpentine Design dPCR Chip 
 
 
Figure 4.9| Zooming into one of the four quadrants of the Serpentine Design dPCR chip. (A) The PCR 
reaction chambers become visible. The figure above shows a more detailed figural display of one quadrant 
of the Serpentine Design dPCR chip. Each of the four quadrants can be seen to have 180 PCR reaction 
chambers in yellow (12 rows x 15 columns). The serpentine design derived from the literal word serpent 
describes the series arrangement of the PCR reaction chambers. The cross interaction between the contents 
of adjacent reaction chambers is prevented by the giant vertical valves (in green) intercepting flow within 
each row. Each Reaction chamber (in yellow) is 1.8 nL. The total number of reaction on this chip are (4 
quadrants× 12 rows × 15 columns) = 720 reaction chambers  
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4.2.2. Digital PCR Attempt Using Serpentine Design dPCR Chip 
 
 
Figure 4.10| Serpentine Design dPCR chip Real-Time monitoring of PCR progression using the 
LightForge System. (A) Raw image taken by LightForge after the 1st PCR cycle. (B) Raw image taken by 
LightForge after the 35th PCR cycle. (C) Matlab processed image taken by LightForge after the 35th PCR 
cycle; (A) and (B) show raw images that the lightForge system captured, showing relatively low 
fluorescence intensity at the beginning of the experiment (1st PCR cycle). As the PCR experiment 
progressed towards the 35th cycle the fluorescence intensity signal relatively got stronger; (C) shows that 
by lowering the background signal, the reactor fluorescence intensity became even more pronounced. The 
reactors (4th row 1st and last columns) that harboured the non-template control maintained relatively 
weaker fluorescence signal even up to the 35th PCR cycle. The 35th cycle image shows that the 1st, 5th, 6th, 
7th and 11th rows confined brightness more than other rows. This confirmed some systematic bias of the 
serpentine chip design because there was no randomness in the pattern of fluorescence signal strength. 
 
4.3. Web Randomising Design dPCR Chip 
 
The Figure 4.11 (below) shows the Web Randomising Design dPCR chip we designed with the idea of 
randomising the flow of the sample. In contrast to the serpentine design described previously, the 
adjacent reactors of the web randomising chip are interconnected allowing fluid to flow in multiple 
directions. 
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4.3.1. The Web Randomising Design dPCR Chip 
 
Figure 4.11| Web Randomising Design dPCR Chip. (A) The rounded interconnected first flow layer that 
has a height of 12 microns, consists of channels linking PCR reaction chambers without outlets, the circular 
features are the inlet/outlet ports of the chip; (B) The hybrid structure that resulted from layering the 180 
microns high PCR reaction chambers (the yellow layer) on top of A thereby yielding a complete Flow Layer 
mold; (C) is the 23 microns high Control mold monolayer consisting of valves that control the sequential 
flow of reagents; (D) is the complete Web Randomising Design dPCR Chip showing how the aligned three 
layers function in conjunction with one another. As can be seen above, the chip is a lot simpler because the 
redundant inlet ports were eliminated. There is only one remaining inlet port and the outlet ports were also 
eliminated to make the chip dead ended. Each Reaction chamber (in yellow) is 1.8 nL. The total number of 
reaction on this chip are (4 quadrants× 12 rows × 15 columns) = 720 reaction chambers 
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4.3.2. Zooming The Web Randomising Design dPCR Chip 
 
Figure 4.12| Zooming into one of the four quadrants of the Web Randomising Design dPCR Chip. (E) Shows 
the detailed features of how the flow layer mold, the PCR reaction chambers (in yellow) become clearly 
visible. (F) Shows the detailed features of the complete Web Randomising Design dPCR Chip, in red are the 
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4.3.3. Digital PCR Attempt Using the Web Randomising dPCR Chip 
 
 
Figure 4.13| Web Randomising Design dPCR Chip Real-Time monitoring of PCR progression using the 
LightForge System. (A) Raw image taken by LightForge after the 1st PCR cycle. (B) Raw image taken by 
LightForge after the 35th PCR cycle. (C) Matlab processed image taken by LightForge after the 35th PCR 
cycle; (C) also shows that the reactors of strong intensity are confined to the quadrant peripheries.  
4.3.4. Deduced Fluid Dynamics when Using the Web Randomising dPCR Chip 
 
 
Figure 4.14| Web Randomising Design dPCR Chip showing evidence of pressure radiating from the 
centre of the quadrant and confining the brightness towards the edges of the chip. It can be seen that the 
reactors at the centre of the quadrant have relatively low fluorescence intensity compared to peripheral 
reactors. 
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4.4. Dead Ended Design dPCR Chip 
 
 
Figure 4.15| Dead Ended Design dPCR Chip. (A) The rounded rows of first flow layer that have a height 
of 12 microns, consists of channels linking PCR reaction chambers without outlets; the circular features 
are the inlet ports of the chip. (B) The hybrid structure that resulted from layering the 180 microns high 
PCR reaction chambers (the yellow layer) on top of A thereby yielding a complete flow layer mold; (C) 
is the 23 microns high Control mold monolayer consisting of valves that control the sequential flow of 
reagents; (D) is the complete Dead Ended Design dPCR chip showing how the aligned three layers 
function in conjunction with one another. Each Reaction chamber (in yellow) is 1.8 nL. The total number 
of reaction on this chip are (4 quadrants× 12 rows × 15 columns) = 720 reaction chambers 
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4.4.1. Digital PCR Attempt Using the Dead Ended Design dPCR Chip 
 
 
Figure 4.16| Dead Ended Design dPCR Chip Real-Time monitoring of PCR progression using the 
LightForge System. (A) Raw image taken by LightForge after the 1st PCR cycle. (B) Raw image taken by 
LightForge after the 35th PCR cycle. (C) Matlab processed image taken by LightForge after the 35th PCR 
cycle, (C) also show some randomness in the brightness pattern in which the PCR chambers lit up. This 
is a random series of positive and negative PCR reactions fashion that we would expect for digital PCR. 
 
In Figure 4.17 we show the demonstrated ability of the LightForge system to simultaneously process 
data from individual PCR reaction chambers. The chambers are numbered sequentially in columns from 
top to bottom as depicted by Figure 4.17(B). In Figure 4.17(C) we only show the data for the first 12 
reactors in the first column. It can be seen that the reactors of weaker fluorescence intensity in Figure 
4.17(B) also had a corresponding weaker real-time amplification signal in Figure 4.17(C). As expected 
again, it can be seen that the reactors of stronger fluorescence intensity in Figure 4.17(B) also had a 
corresponding stronger real-time amplification signal in Figure 4.17(C). The data for the rest of the 
reactors is shown in Appendix B. This reveals the potential of the LightForge system to be a highly 
scalable platform for real-time PCR and HRMA; because we can monitor in real-time, the progression 
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4.4.2. LightForge Scalability 
 
  
Figure 4.17| Dead Ended Design dPCR Chip Real-Time monitoring. With 50% H37RV rpoB region PCR 
amplicons using the LightForge System. (A) Raw image taken by LightForge after the 1st PCR cycle. (B) Raw 
image taken by LightForge after the 35th PCR cycle. (C) Multi-graph plot showing the real-time amplification, 
Normalised HRMA curve and the negative 1st derivative plot of some of the PCR reaction chambers in the 1st 
column (See Appendices for profiles corresponding to each of the reactors shown in image (C) In (B) we see 
that the PCR chamber 1 amplified as its relative fluorescence intensity increased in comparison to (A). This 
observation is in consistency with what (C) shows the reactor numbering system done by the LightForge system 
(sequentially from top to bottom); for reactor 1 there is a significant real-time amplification signal, a normalised 
HRMA curve with a corresponding melting temperature of 80.9119 °C. This temperature was determined by 
taking the temperature that corresponded to the maximum value of y on the 1st derivative melt plot for this PCR 
reaction chamber. It was also observed that reaction chambers 5, 6 and 7 had melting temperatures of 80.9629 
°C, 82.8528 °C and 80.9453 °C respectively. PCR reaction chambers 2, 3, 4, 8, 9, 10, 11 and 12 did not yield 
a legitimate peak implying the initial absence of a DNA copy in them at the beginning of the experiment. The 
LightForge microfluidic system we developed demonstrated the capability of processing large amounts of real 
time fluorescence data from different reaction chambers in parallel.v   
 





5.1.  LightForge Real-Time PCR and HRMA 
 
Amidst nucleic acid amplification tests (NAATs), qPCR has been widely employed for molecular 
diagnosis and technological applications that detect and quantify pathogens [131].  PCR microfluidic 
systems of various designs have been developed for effective and fast DNA amplification by many 
research groups. These comprise of chamber stationary PCR[132, 133] and flow-through PCR[134], as 
well as thermal convection-driven PCR[135]. Alternatively, we have now built an automated rapid 
prototype instrument shown in Figure 3.3 (Materials and Methods Section Chapter 3) that rapidly 
performs PCR and HRMA using microfluidic chips of different designs. Real-time PCR, High 
Resolution Melt Analysis (HRMA) and SNP genotyping with fluorescent DNA saturating dyes can be 
performed within a disposable LightForge microfluidic chip at over two thousand-fold reduction in 
analysis volume from current conventional PCR commercial systems. The LightForge PCR and HRMA 
system takes over 3 hours to complete the assay. However, future embedding the PCR reaction 
chambers with thin film resistive heaters and temperature sensors will enable thousands of real-time 
PCR experiments to rapidly occur in parallel followed by detection at endpoint using HRMA.  
 
5.2.  Single Nucleotide Polymorphism (SNP) Resolution  
 
In comparison with conventional PCR instruments, the LightForge system dramatically allows for 
highly scalable assays because of automated sample operation. To demonstrate data quality of HRMA 
melting curves for this study, we have developed PCR/HRMA assays to detect particular mutations 
associated with drug resistance within rpoB, the 81-bp rifampicin resistance determining region 
(RRDR). We performed this for rifampicin resistant conferring SNPs present in Mtb clinical isolates, 
namely, R35, KZN 605 and TKK-01-062. The reference for this detection was an rpoB region of a 
rifampicin susceptible strain H37RV. The gyrA (wild type), a 234-bp region that includes several 
resistance-associated sites (OFLX resistance in other strains) was used as a positive control. 
 
The development of non-specific ds-DNA binding dyes that include SYTO 9 and LC Green has 
increased the stability and sensitivity of HRMA assays by making it possible to distinguish minute 
melting temperature differences[136]. In summary according to the Bioline website, the following 
commercial systems; (ABI 7300, 7500 FAST, Qiagen Rotor-Gene™ 6000, Eppendorf Mastercycler® ep 
realplex, Illumina® Eco™, Roche LightCycler®; 96 and 480, Bio-Rad Opticon®, CFX96™, CFX384™, 
Idaho LightScanner® 32 (LS32™), Takara Thermal Cycler Dice (TP800))  as shown in Table 5.1 
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(below) for instance, (> 0.5 °C for SNP class 1 and 2 mutations); (> 0.2 °C and < 0.5 °C for SNP class 
3 mutations); and (< 0.2 °C for SNP class 4 mutations) Tm differences are registered if the SensiFAST™ 
HRM-kit is used[137]. In this project as we investigated class 1 and 4 SNP Tm differences on the 
LightForge platform we found them to be largely exacerbated in comparison to the systems noted above. 
However, this exacerbation occurred in a trend that is in harmony with what is observed for most 
commercial bulk PCR systems. Table 5.1 (below) shows that the LightForge system is at least two-fold 
better at detecting Class 1 SNPs. When we considered Class 4 SNPs which are a lot more difficult to 
detect in most commercial systems, LightForge showed potential to distinguish these by greater than 
0.2 °C (as opposed to less than 0.2 °C offered by current commercial systems). 
 
Table 5.1|Comparison between LightForge and the Bioline SensiFAST™ HRM-kit commercial 
system melting temperatures (Tm). 




1 C↔T and G↔A Large > 0.5 °C > 1 °C 
2 C↔A and G↔T Large > 0.5 °C  
3 C↔G Small 0.2 - 0.5 °C  
4 A↔T Small < 0.2 °C > 0.2 °C 
 
 
5.3.  LightForge Perfomance 
 
In this section we discuss our LightForge system in relation towards its satisfying the following criteria 
fundamentally important for a clinically useful molecular diagnostic tool: 
 
1. Scalability: In comparison to single stationary chamber PCR microfluidics that has been 
developed and widely investigated by other groups [138-141], the LightForge platform provides 
a highly scalable multi-chamber stationary PCR microfluidics. This has improved factors such 
as PCR throughput, analysis time and minimised errors through automation. Nonetheless 
investigation into the thermal design to ascertain temperature uniformity between the chambers 
is still to be conducted. The temperature uniformity is very critical since it bears influence on 
reliability, repeatability, sensitivity, efficiency and specificity of PCR amplification across 
different chambers[142].  
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2. Assay time: The LightForge system demonstrated that it requires over 3 ½ hours to complete 
real-time PCR and HRMA. In comparison to the flow-through PCR, this duration is relatively 
long. In flow-through PCR microfluidics the stationary chambers are replaced by flowing the 
PCR master mix solution continuously and repeatedly through three different temperature zones 
required for PCR amplification [143]. However, this advantage of having shorter PCR time is 
achieved at costs that are partly addressed by the LightForge system. The costs include a fixed 
number of cycles that are dictated by the chip design, automation of realtime data acquisition 
and multiplexing of assays which are very challenging when using the flow-through PCR 
microfluidics approach. It can also be argued that 3 ½ for thousands of PCR experiments on a 
LightForge platform can certainly be better than conducting a few hundreds of PCR experiments 
for 1 hour in conventional systems such as the Roche LightCycler® 480[144]. 
 
3. Surface treatment: The LightForge platform demonstrated its capability to do real-time PCR and 
HRMA on a chip. This was only achieved as a proof of principle by employing the dynamic 
surface passivation approach. In this approach the passivation occurred during the practical 
operation of the microfluidic PCR when we added the non-ionic surfactant Tween 20 to the PCR 
master mix solution as a passivation agent. Although we only optimised Tween 20 in our assays, 
there are several passivation agents that can be investigated in pursuit of an improved signal in 
future. These agents include protein adjuvant-Bovine Serum Albumin (BSA) and polymer based 
solutions such as polyethylene glycol (PEG)[142]. LightForge microfluidic chips can also be 
subjected to static passivation where we pre-coat the inner surfaces of the channels using 
substances compatible with PCR during fabrication. This may involve silicon oxide or chemicals 
that act as salinizing agents[145, 146]. 
 
4. Data acquisition: Many researchers have explored end point detection of PCR products by 
measuring fluorescence after PCR completion to establish the success or failure of 
amplification[132, 147]. However, this approach of inferring initial target DNA concentration 
based on the ultimate amplified PCR products is very unreliable[142]. The LightForge system 
we have developed has the potential to resolve some of these challenges as it can kinetically 
quantify fluorescence signals that result from the binding of LC Green fluorescence dye as a 
function of the increasing double stranded DNA copies. We have also demonstrated that 
LightForge has the ability to detect the yields of a PCR as soon as the products increase 
appreciably to the detection threshold in contrast to waiting until completion of all pre-
programed PCR cycles.  
 
5. Sensitivity: Analytical sensitivity is a very critical parameter of any diagnostic qPCR test 
especially with Mycobacteria tuberculosis where research has shown paucibacillary nature in 
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paediatrics and immunocompromised individuals [148, 149]. The aspects affecting sensitivity 
of PCR microfluidics have not been widely studied despite research showing that detection of 
rare targets or trace genomic material from environmental and/or clinical samples is a great 
challenge for microfluidic devices [150]. In addition, inconsistencies in the reaction chemistry 
(e.g., in salt concentration) is known to significantly alter the HR-Melting temperature[151]. In 
this study, the LightForge platform in conjunction with the dead ended digital PCR chip (Figure 
4.15 Results Chapter 4) with reactor chamber volumes of 1.8 nL demonstrated its potential to 
detect DNA concentrations within the digital realm (individual Mtb genomes per chamber). The 
81-bp RIF resistance determining region (RRDR) rpoB, was adequately amplified with a total 
of 35 cycles in about 3 ½ hrs. The sensitivity of LightForge PCR microfluidics was demonstrated 
with its ability to amplify the rpoB gene at concentrations of DNA that theoretically allow only 
50% of 180 PCR chambers of the dead ended digital PCR chip to brighten up. This shows 
potential for future heterogeneity studies on this LightForge platform. 
 
6. Specificity: By definition this is the fraction of samples without the target analyte that generates 
a positive result and technically an ideal assay should have this fraction as zero[149]. The signal 
that was detectable using the LightForge real-time PCR assay step had contribution from both 
specific and non-specific products; hence this bears implication on the qualitative or quantitative 
result of the analysis. To circumvent this problem, the post PCR HRMA using LC Green DNA 
saturating fluorescent dye confirmed the specificity of the assay since distinct melt profiles were 
recorded for specific samples. For instance; i) replicated overlapping 1st derivative melt peaks 
corresponding to the 81-bp RIF resistance determining region (RRDR) rpoB amplicon, ii) 
replicated overlapping positive control peaks for 234-bp gyrA region amplicons that includes 
several OFLX resistance-associated sites (See Figure 4.7 Results Chapter 4) and iii) distinctly 
profiled non template control signal were differentiated. However, as previously discussed the 
temperature uniformity of the heating block was unreliable and imprecise from one experiment 
to the next. This is a very critical drawback of the system that bore influence on efficiency and 
specificity of PCR amplification across different chambers thereby restricting us to confidently 
tally a specific melting temperature to an Mtb clinical strain mutation. However, our 
incorporation of a susceptible H37RV standard as a reference strain allowed us to distinguish 
specific classes of SNP genotyping within drug resistant Mtb strains. This distinction was done 
in a manner that is in agreement with what most commercial systems do. 
 
7. Simplicity: We chose PCR as a diagnostic assay since it has been well renowned for many years 
and its advantages and disadvantages are widely understood[149]. Furthermore, with the recent 
invention of HRMA as a simple and effective method for characterising PCR products[136], we 
saw this as an opportunity to develop a SNP genotyping platform. The LightForge system we 
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have built does not only integrate PCR and HRMA but also has the ability to automatically 
handle and manipulate fluids at a nanoscale. This strength gives it potential to contribute towards 
accuracy and repeatability of assays by minimum need for human involvement. The LightForge 
system has a controlling computer algorithm that runs on a temperature feedback loop. This 
implies that the sequence of events carried by the system is dictated by the thermal instructions 
allowing the 3 step PCR to occur and HRMA directly following. The Cepheid GeneXpert® has 
shown promise as an automated desktop machine with capability of conducting real-time PCR 
and simultaneously detecting Mycobacrteria tuberculosis as well as rifampicin resistance 
directly from sputum[27]. This is the typical simplicity we project for the highly scalable 
LightForge platform by future incorporation of a sputum processing module that is able to extract 
microbes and lyse them leading to the release of genomic material prior to real-time PCR and 
HRMA.  
 
8. Cost: The trend towards smaller reaction volumes by PCR microfluidics is being largely 
influenced by the fact that PCR reagents are very expensive. Furthermore, the communities that 
are largely in need of diagnostic services cannot afford currently available assays. The current 
PCR-based gold standard, the Cepheid GeneXpert®, presents with an important limitation 
because of its cost which is highly prohibitive for a disease that principally affects poor 
community settings. The pricing of the GeneXpert has been tiered and heavily subsidised for 
developing countries. A single Cepheid GeneXpert® machine costs between US$17,000-
$62,000. Furthermore the single use disposable test-cartridges cost between US$17-$120[27]. 
Our miniaturized LightForge PCR microfluidic devices bring many improvements towards 
decreased cost of fabrication and usage. The system we have built shows potential towards 
reduced consumption of biological sample and reagents necessary for PCR; label free detection; 
long shelf life; and economical disposal of the used PCR chips. In addition, the LightForge 
system’s ability to cost effectively perform large numbers of parallel PCR amplifications and 
HRMA analyses on a single PCR microfluidic chip can lead to the generation of more accurate 
information. This will ultimately translate to a greater understanding of particular bioassays, 
which are currently costly, challenging, impractical, or even hopeless to perform on macro-scale 
PCR devices. Since TB mainly affects people in low income settings who cannot afford to pay 
the current costs for diagnostics and treatment, the potential principal solution to this challenge 
is the LightForge system. Therefore, we believe that the LightForge system has the potential to 
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5.4.  Possible Future LightForge System Applications 
 
5.4.1. Digital PCR 
 
The current PCR based gold standard systems for diagnosis, are analog in nature, with a population 
averaged diagnostic indicator being measured from the total sample volume[152]. With the high 
scalability nature of the LightForge system, it has potential to bring a solution to this problem by 
utilising digital PCR (dPCR). Digital PCR is a refinement of conventional PCR that is performed by 
partitioning a minimally diluted sample and conventional PCR mixture into very large number of 
separate reaction volumes, such that there is either one target molecule or zero per individual 
reaction[23]. The LightForge system demonstrated the fundamental concept of making digital 
measurements as can be seen in Figure 4.16(C) (Results Chapter 4) which shows the image after 
thermal cycling performed to endpoint. All target containing reaction chambers became brightly 
fluorescent while compartments without targets only displayed background fluorescence. This approach 
can be statistically validated by Poisson distribution statistics where the chances of target molecules to 
be co-located in the same chamber can be calculated and put into account[153]. Having true single target 
molecules to be interrogated in isolation allows for multiplex or heterogeneity investigating assays to 
be conducted[23].  
 
Lenaerts and her team recently reported that Tuberculosis lesions are complex and consist of extremely 
dynamic microenvironments. They further suggest that immunopathological diversity of cavities and 
granulomas creates a plethora of microenvironments that force M. tuberculosis bacilli to adapt. This 
ultimately affects processes such as metabolism, DNA replication and relatively the density of microbial 
subpopulation. All these factors subsequently lead to respective susceptibility or resistance to 
chemotherapeutic agents[128]. This mechanism is believed to be another major driving force towards 
heterogeneity as well as MDR and XDR-TB development among patients. Therefore the future 
applications of LightForge are directed towards detecting this heterogeneity from the onset to guide 
proper dispensation of medicines. Digital PCR (dPCR) is a very versatile technique with many research 
groups having demonstrated its versatility. For instance, it has been used for the detection of rare alleles 
in cancer cells or genetic disorders as well as RNA viral load detection[154, 155]. It has also been used 
to study gene expression and copy number variations in heterogeneous cell populations as well as to run 
a quality control tests on DNA samples before sequencing [156-158]. This technology can also be 
applied to assays with limited sample material. These are some of the future possibilities that the 
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5.4.2. Other Applications 
 
The versatility of LightForge PCR microfluidics through compatibility with a variety of architectures, 
displays wide future biomedical and bioanalytical applications conveniently at a cheaper cost. Some of 
these applications may involve bacterial contamination and/or infection detection- including 
E.coli[159]; Salmonella typhimurium[160]; M. tuberculosis[161]. Viral infection detection including 
Human Immunodeficiency Virus (HIV)[162]; human papillomavirus (HPV)[133]; hepatitis virus[163]; 
and Protozoan parasitic infection detection including malaria[164]. Another possible area of application 
would be in pharmacogenetics, where we could use the system to rapidly detect inherited differences in 
drug targets, and drug disposition in the form of drug receptors as well as drug transporters[165]. 
However it should be noted that the applications of LightForge PCR microfluidics are not potentially 
confined to the fields we mentioned here. Principally, in future the LightForge system technology can 
be applied to many cases where minute nucleic acid materials DNA/RNA have to be amplified and 
analysed subsequently. These are just some of the possibilities that the LightForge system can achieve 
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CHAPTER 6 
6. Conclusions  
Principally we have demonstrated that the fully automated LightForge system we have developed at K-
RITH offers a highly scalable microfluidic platform for interrogation of tuberculosis strains using Real-
Time PCR and High Resolution Melt Analysis (HRMA) on a chip. We have used this system to identify 
clinical TB strains resistant to rifampicin—a frontline drug used to treat tuberculosis; relative to a 
susceptible strain H37RV, based on mutations in the rpoB gene. This system has the potential to 
contribute towards a low-cost solution for diagnosis of multidrug resistant tuberculosis—a critical 
global healthcare challenge. LightForge system has detected mutations linked to rifampicin resistance, 
including single nucleotide polymorphisms (SNPs), in a manner harmonious with commercial systems. 
In preparation for diagnosis of clinical isolates, this LightForge approach is now being expanded to 
incorporate detection of genetic markers linked with resistance to other TB drugs that include gyrA for 
fluoroquinolones; and katG/Mab-inhA for isoniazid[166]. Future PCR assays that are attuned to any 
resistance conferring molecular signature can be developed using appropriate probes to improve 
LightForge specificity. Our top priority at the moment is to make further efforts to improve the 
LightForge system’s sensitivity; specificity; speed; heteroresistance detection capacity—through dPCR; 
and simplicity towards low cost solution to Mycobacterium tuberculosis resistance detection. The real-
time PCR and HRMA demonstrated by the LightForge system are potentially applicable not only to 
Mycobacterium tuberculosis but also to other pathogens. This includes the capability to accurately 
diagnose mixed infections, detect drug-resistant strains, and render other genetic markers available as 
diagnostic tools for laboratory and field environments. We also plan to integrate PCR with sample 
preparation on a single chip as currently sample pre-preparation is still required. This is useful when 
using environmental or otherwise very complex samples such as whole blood that may contain PCR 
inhibiting contaminants. Although the current version of the LightForge system relies on a microscope 
and a camera, future improvement considerations include employing other methods amenable with 
miniaturization such as surface plasmon resonance (SPR).  
In conclusion, it is conceivable that the LightForge system could address not only Mycobacterium 
tuberculosis but also a variety of other tropical diseases in both developed and underserved regions. 
















British Prime Minister Robert Peel on Michael Faraday’s discoveries on electricity and 
magnetism 
Prime Minister: “What good is it?” 
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THESIS APPENDICES 
Appendix A: Microfabrication Protocols of PCR Microfluidic Chips. 
 




Layer 1 (Positive Photoresist) 
 
Priming:                  HDMS vapor 2 min in plastic container (STP)  
Spin MAP 1275:    1200 rpm x 60 s, Acceleration=133rpm/sec  
             Film thickness = 11 microns  
Soft Bake:               contact bake on hotplate  
             95 °C x 90 s  
Expose Wafer:        15 sec on mask aligner 
Develop:                 ma-D 531 Developer, rinse with deionised water (H
2
O) 
                                and dry under house dry air with and air gun  
Incubate:                 Overnight at room temperature, light shielded 
Rounding:               Contact bake on hotplate 
                                65 °C x 3 min and115 °C x 15 min  
Profile:                    Profilometer (KLA Tencor D-120) to establish height and geometry  
Hard Bake:             Thermoscientific oven: a) Set oven to 120 °C and place mold 
                                                                       b) Ramp up 120 °C to 180° C  
                                                   c) Hold oven for 1 hr at 180 °C  
                                                   d) Ramp down180 °C to 120 °C  
Cooling:                   To room temperature 
 
Layer 2 (Negative Photoresist) 
 
Spin SU8 100:          1200 rpm x 60 s, Acceleration = 100 rpm/sec  
               Film thickness = 190 microns  
Pre-Exposure Bake:  contact bake on hotplate  
               5 min x 65 °C / 30 min x 95 °C / 1 min x 65 °C 
Expose Wafer:          150 sec 
Post-Exposure Bake: 2 min x 65 C / 12 min x 95 C / 1 min x 65 C  
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Develop:                    100 % SU-8 Developer, rinse with fresh developer  
                                   dry under house dry air with an air gun 
 
Control Mold (Negative Photoresist) 
 
Spin SU8 2015:         1500 rpm x 60 s, Acceleration= 270 rpm/sec 
                Film thickness = 23 microns  
Pre-Exposure Bake:   contact bake on hotplate  
                3 min x 65 °C / 5 min x 95 °C  
Expose Wafer:           5 sec 
Post-Exposure Bake: 5 min x 65 °C / 15 min x 95 °C  
Develop:                   100 % SU-8 Developer, rinse with fresh developer  
                                   dry under house dry air with an air gun  
 
MSL Fabrication  
Priming:                              all molds except for dummy layer, 
                                            TMCS vapor 3 min in plastic container (STP) 
Flow layer 
Cast Flow Layer:                combine 5:1 GE 615 RTV (75 g A: 15 g B)  
mix hybrid mixer:               5 min mix / 5 min degas  
Molding:                             60 g onto flow mold (150mm petri dish lined with Al foil)  
Degas Flow Layer:             pull vacuum in bell jar (approx 30 minutes) 
 
Control Layer  
 
Spin Control Layer:           combine 20:1 GE 615 RTV (40 g A: 2 g B)  
Mix hybrid mixer:              5 min mix / 5 min degas  
Molding:                            dispense 5 mL on control layer  
                        1800 rpm x 60 s / Acceleration =500 rpm/sec 








  School of LM & MS                                           85                                                        University of KwaZulu-Natal 
 
 
Spin Blank Layer:              combine 20:1 GE 615 RTV (40 g A: 2 g B)  
mix hybrid mixer:              5 min mix / 5 min degas  
Molding:                            dispense 5 mL on blank 3’ wafer 2000 rpm x 60 s / 15 s ramp  
                        Film thickness = 30 microns 
Curing 
Cure Flow Layer:              Binder® oven 80 C x 40 min  
Cure Control Layer:          Binder® oven 80 C x 40 min  
Cure Blank Layer:             C x 40 min  
 
Bonding 
Flow Peeling:                    Peel flow layer from mold, punch all flow inlet and outlet ports 
Cutting:                             Cut around periphery of desired flow layer area. 
Control/ Flow Bonding:    Align to control layer using the Olympus SZX16 microscope  
                        Bake in convection oven 80 C x 40 min 
Cutting:                             Cut around periphery of thick layer avoiding damage to the mold   
Peel Hybrid:                      Peel bonded hybrid device from control mold   
                                          Punch all control ports  
Blank/Hybrid Bonding:    Place control/flow hybrid structure on blank,  
                                          ensuring no air bubbles, no collapsed valves  
                       Binder® oven 80 °C x 8 hours  
Final Inspection:               Quality control is done through inspection using the  
                                          Olympus SZX16 microscope 
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Layer 1 (Positive Photoresist) 
 
Priming:                  HDMS vapor 2 min in plastic container (STP)  
Spin MAP 1275:    1200 rpm x 60 s, Acceleration=133rpm/sec  
             Film thickness = 11 microns  
Soft Bake:               contact bake on hotplate  
             95 °C x 90 s  
Expose Wafer:        15 sec 
Develop:                 ma-D 531 Developer, rinse with deionised water (H
2
O) 
                                and dry under house dry air with air gun  
Incubate:                 Overnight at room temperature, light shielded 
Rounding:               Contact bake on hotplate 
                                65 °C x 3 min and115 °C x 15 min  
Profile:                    Profilometer (KLA Tencor D-120) to establish height and geometry 
Hard Bake:             Thermoscientific oven: a) Set oven to 120 °C and place mold 
                                                                       b) Ramp up 120 °C to 180° C  
                                                    c) Hold oven for 1 hr at 180 °C  
                                                    d) Ramp down180 °C to 120 °C  
Cooling:                   To room temperature 
 
Layer 2 (Negative Photoresist) 
Spin SU8 100:          1200 rpm x 60 s, Acceleration = 100 rpm/sec 
               Film thickness = 180 microns  
Pre-Exposure Bake:  contact bake on hotplate  
               5 min x 65 °C / 30 min x 95 °C / 1 min x 65 °C 
Expose Wafer:          150 sec 
Post-Exposure Bake: 2 min x 65 C / 12 min x 95 C / 1 min x 65 C  
Develop:                    100 % SU-8 Developer, rinse with fresh developer  
                                   dry under house dry air with an air gun  
 
Control Mold (Negative Photoresist) 
Spin SU8 2015:         1500 rpm x 60 s, Acceleration= 270 rpm/sec  
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                Film thickness = 23 microns  
Pre-Exposure Bake:   contact bake on hotplate  
                3 min x 65 °C / 5 min x 95 °C  
Expose Wafer:           5 sec 
Post-Exposure Bake: 5 min x 65 °C / 15 min x 95 °C  
Develop:                   100 % SU-8 Developer, rinse with fresh developer  
                                   dry under house dry air with an air gun  
 
MSL Fabrication  
Priming:                              all molds except for dummy layer, 
                                            TMCS vapor 3 min in plastic container (STP) 
Flow layer 
Cast Flow Layer:                combine 5:1 GE 615 RTV (75 g A: 15 g B)  
mix hybrid mixer:               5 min mix / 5 min degas  
Molding:                             60 g onto flow mold (150mm petri dish lined with Al foil)  
Degas Flow Layer:             pull vacuum in bell jar (approx 30 minutes) 
 
Control Layer  
Spin Control Layer:           combine 20:1 GE 615 RTV (40 g A: 2 g B)  
Mix hybrid mixer:              5 min mix / 5 min degas  
Molding:                            dispense 5 mL on control layer  
                        1800 rpm x 60 s / Acceleration =500 rpm/sec 
                        Film thickness = 28 microns  
Dummy layer 
Spin Blank Layer:              combine 20:1 GE 615 RTV (40 g A: 2 g B) 
mix hybrid mixer:              5 min mix / 5 min degas  
Molding:                            dispense 5 mL on blank 3’ wafer 2000 rpm x 60 s / 15 s ramp  
                        Film thickness = 30 microns 
Curing 
Cure Flow Layer:              Binder® oven 80 C x 40 min  
Cure Control Layer:          Binder® oven 80 C x 40 min  
Cure Blank Layer:             C x 40 min  
 
Bonding 
Flow Peeling:                    Peel flow layer from mold, punch all flow inlet and outlet ports 
Cutting:                             Cut around periphery of desired flow layer area. 
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Control/ Flow Bonding:    Align to control layer using the Olympus SZX16 microscope  
                        Bake in convection oven 80 C x 40 min 
Cutting:                             Cut around periphery of thick layer avoiding damage to the mold   
Peel Hybrid:                      Peel bonded hybrid device from control mold   
                                          Punch all control ports  
Blank/Hybrid Bonding:    Place control/flow hybrid structure on blank,  
                                          ensuring no air bubbles, no collapsed valves  
                       Binder® oven 80 °C x 8 hours  
Final Inspection:               Quality control is done through inspection using the  
                                          Olympus SZX16 microscope 
 





  School of LM & MS                                           89                                                        University of KwaZulu-Natal 
 




Layer 1 (Positive Photoresist) 
 
Priming:                  HDMS vapor 2 min in plastic container (STP)  
Spin MAP 1275:    1200 rpm x 60 s, Acceleration=133rpm/sec  
             Film thickness = 11 microns  
Soft Bake:               contact bake hotplate  
             95 °C x 90 s  
Expose Wafer:        15 sec 
Develop:                 ma-D 531 Developer, rinse with deionised water (H
2
O) 
                                and dry under house dry air with an air gun  
Incubate:                 Overnight at room temperature, light shielded 
Rounding:               Contact bake on hotplate 
                                65 °C x 3 min and115 °C x 15 min  
Profile:                    Profilometer (KLA Tencor D-120) to establish height and geometry   
Hard Bake:             Thermoscientific oven: a) Set oven to 120 °C and place mold 
                                                                       b) Ramp up 120 °C to 180° C  
                                                    c) Hold oven for 1 hr at 180 °C  
                                                    d) Ramp down180 °C to 120 °C  
Cooling:                   To room temperature 
 
Layer 2 (Negative Photoresist) 
Spin SU8 100:          1200 rpm x 60 s, Acceleration = 100 rpm/sec 
               Film thickness = 168 microns  
Pre-Exposure Bake:  contact bake on hotplate  
               5 min x 65 °C / 30 min x 95 °C / 1 min x 65 °C 
Expose Wafer:          150 sec 
Post-Exposure Bake: 2 min x 65 C / 12 min x 95 C / 1 min x 65 C  
Develop:                    100 % SU-8 Developer, rinse with fresh developer  
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Control Mold (Negative Photoresist) 
Spin SU8 2015:         1500 rpm x 60 s, Acceleration= 270 rpm/sec  
                Film thickness = 23 microns  
Pre-Exposure Bake:   contact bake on hotplate  
                3 min x 65 °C / 5 min x 95 °C  
Expose Wafer:           5 sec 
Post-Exposure Bake: 5 min x 65 °C / 15 min x 95 °C  
Develop:                   100 % SU-8 Developer, rinse with fresh developer  
                                   dry under house dry air with an air gun  
 
MSL Fabrication  
Priming:                              all molds except for dummy layer, 
                                            TMCS vapor 3 min in plastic container (STP) 
Flow layer 
Cast Flow Layer:                combine 5:1 GE 615 RTV (75 g A: 15 g B)  
mix hybrid mixer:               5 min mix / 5 min degas  
Molding:                             60 g onto flow mold (150mm petri dish lined with Al foil)  
Degas Flow Layer:             pull vacuum in bell jar (approx 30 minutes) 
 
Control Layer  
Spin Control Layer:           combine 20:1 GE 615 RTV (40 g A: 2 g B)  
Mix hybrid mixer:              5 min mix / 5 min degas  
Molding:                            dispense 5 mL on control layer  
                        1800 rpm x 60 s / Acceleration =500 rpm/ sec 
                        Film thickness = 28 microns  
Dummy layer 
Spin Blank Layer:              combine 20:1 GE 615 RTV (40 g A: 2 g B)  
mix hybrid mixer:              5 min mix / 5 min degas  
Molding:                            dispense 5 mL on blank 3’ wafer 2000 rpm x 60 s / 15 s ramp  
                        Film thickness = 30 microns 
Curing 
 
Cure Flow Layer:              Binder® oven 80 C x 40 min  
Cure Control Layer:          Binder® oven 80 C x 40 min  
Cure Blank Layer:             C x 40 min  
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Bonding 
Flow Peeling:                    Peel flow layer from mold, punch all flow inlet and outlet ports 
Cutting:                             Cut around periphery of desired flow layer area. 
Control/ Flow Bonding:    Align to control layer using the Olympus SZX16 microscope  
                        Bake in convection oven 80 C x 40 min 
Cutting:                             Cut around periphery of thick layer avoiding damage to the mold   
Peel Hybrid:                      Peel bonded hybrid device from control mold   
                                          Punch all control ports  
Blank/Hybrid Bonding:    Place control/flow hybrid structure on blank,  
                                          ensuring no air bubbles, no collapsed valves  
                       Binder® oven 80 °C x 8 hours  
Final Inspection:               Quality control is done through inspection using the  
                                          Olympus SZX16 microscope 
 
* spin parameters need to be optimized for each batch. 
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Layer 1 (Positive Photoresist) 
Priming:                  HDMS vapor 2 min in plastic container (STP)  
Spin MAP 1275:    1200 rpm x 60 s, Acceleration=133rpm/sec  
             Film thickness = 11 microns  
Soft Bake:               contact bake hotplate  
             95 °C x 90 s  
Expose Wafer:        15 sec 
Develop:                 ma-D 531 Developer, rinse with deionised water (H
2
O)                                and dry 
under house dry air with an air gun  
Incubate:                 Overnight at room temperature, light shielded 
Rounding:               Contact bake on hotplate 
                                65 °C x 3 min and115 °C x 15 min  
Profile:                    Profilometer (KLA Tencor D-120) to establish height and geometry  
Hard Bake:             Thermoscientific oven: a) Set oven to 120 °C and place mold 
                                                                       b) Ramp up 120 °C to 180° C  
                                                    c) Hold oven for 1 hr at 180 °C  
                                                    d) Ramp down180 °C to 120 °C  
Cooling:                   To room temperature 
 
Layer 2 (Negative Photoresist) 
Spin SU8 100:           1200 rpm x 60 s, Acceleration = 100 rpm/sec  
               Film thickness = 158 microns  
Pre-Exposure Bake:  contact bake hotplate  
               5 min x 65 °C / 30 min x 95 °C / 1 min x 65 °C 
Expose Wafer:          150 sec 
Post-Exposure Bake: 2 min x 65 C / 12 min x 95 C / 1 min x 65 C  
Develop:                    100 % SU-8 Developer, rinse with fresh developer  
                                   dry under house dry air with air gun  
 
Control Mold (Negative Photoresist) 
Spin SU8 2015:         1500 rpm x 60 s, Acceleration= 270 rpm/sec  
                Film thickness = 23 microns  
Pre-Exposure Bake:   contact bake on hotplate  
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                3 min x 65 °C / 5 min x 95 °C  
Expose Wafer:           5 sec 
Post-Exposure Bake: 5 min x 65 °C / 15 min x 95 °C  
Develop:                   100 % SU-8 Developer, rinse with fresh developer  
                                   dry under house dry air with an air gun  
MSL Fabrication  
Priming:                              all molds except for dummy layer, 
                                            TMCS vapor 3 min in plastic container (STP) 
Flow layer 
Cast Flow Layer:                combine 5:1 GE 615 RTV (75 g A: 15 g B)  
mix hybrid mixer:               5 min mix / 5 min degas  
Molding:                             60 g onto flow mold (150mm petri dish lined with Al foil)  
Degas Flow Layer:             pull vacuum in bell jar (approx 30 minutes) 
 
Control Layer  
 
Spin Control Layer:           combine 20:1 GE 615 RTV (40 g A: 2 g B)  
Mix hybrid mixer:              5 min mix / 5 min degas  
Molding:                            dispense 5 mL on control layer  
                        1800 rpm x 60 s / Acceleration =500 rpm/ sec 
                        Film thickness = 28 microns  
Dummy layer 
Spin Blank Layer:              combine 20:1 GE 615 RTV (40 g A: 2 g B) 
mix hybrid mixer:              5 min mix / 5 min degas  
Molding:                            dispense 5 mL on blank 3’ wafer 2000 rpm x 60 s / 15 s ramp  
                        Film thickness = 30 microns 
Curing 
Cure Flow Layer:              Binder® oven 80 C x 40 min  
Cure Control Layer:          Binder® oven 80 C x 40 min  
Cure Blank Layer:             C x 40 min  
 
Bonding 
Flow Peeling:                    Peel flow layer from mold, punch all flow inlet and outlet ports 
Cutting:                             Cut around periphery of desired flow layer area. 
Control/ Flow Bonding:    Align to control layer using the Olympus SZX16 microscope  
                        Bake in convection oven 80 C x 40 min 
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Cutting:                             Cut around periphery of thick layer avoiding damage to the mold   
Peel Hybrid:                      Peel bonded hybrid device from control mold   
                                          Punch all control ports  
Blank/Hybrid Bonding:    Place control/flow hybrid structure on blank,  
                                          ensuring no air bubbles, no collapsed valves  
                       Binder® oven 80 °C x 8 hours  
Final Inspection:               Quality control is done through inspection using the  
                                          Olympus SZX16 microscope 
 
* spin parameters need to be optimized for each batch. 
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fclose all; clear all; close all; 
tic; 
%Set up directories 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
file_name = 'High_Resolution_MeltRecords.xls'; 
file_name2 = 'Real_time_PCR_Records.xls'; 
  
data_directory = 'C:\Usersxxxxxxx' 
my_file_name = strcat(data_directory,'\',file_name); 
my_file_name2 = strcat(data_directory,'\',file_name2); 
  
Temp_inc = 0.00001; 
num_pts = 10000; 
  
Amplif_data_array(1,1) = 0; 
Amplif_Array = dlmread(my_file_name2); 
my_ampliffile_name = strcat(file_name2,'Amplif.xls'); 
  
Melt_data_array(1,1) = 0; 
Melt_Array = dlmread(my_file_name); 
my_meltfile_name = strcat(my_file_name,'melt.xls'); 
  
Smoothed_data_array(1,1) = 0; 
Smoothed_array = dlmread(my_file_name) 
my_smoothedfile_name = strcat(my_file_name,'smooth.xls');         
  
Norm_smoothed_data_array(1,1) = 0; 
Norm_smoothed_array = dlmread(my_file_name); 
my_norm_smoothedfile_name = strcat(my_file_name,'norm_smooth.xls'); 
  
Raw_data_array(1,1) = 0; 
Raw_array = dlmread(my_file_name); 
my_rawfile_name = strcat(my_file_name,'raw.xls'); 
  
%Melt_Array = dlmread('C:\Users\tawanda.mandizvo\Documents\Masters Research\Matlab\mbano man 
rpob03Jun2014_03_45PM0\Records_MeltC.txt'); 
  
X0 = Melt_Array(:,3); 
max_index = find(X0 == max(X0(:)));  %max_index = find(Array == max(Array)) 
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for react = 5:41  %5:25 
     
    reactor_count = reactor_count+1; 
    Y0 = Melt_Array(:,react); 
    Y = Y0(1:max_index); 
     
    %Y = (Y1 - min(Y1)) / ( max(Y1) - min(Y1) ); 
    
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%% 
    f_ = clf; 
    figure(f_); 
    set(f_,'Units','Pixels','Position',[658 269 688 485]); 
    % Line handles and text for the legend. 
    legh_ = []; 
    legt_ = [3]; 
    % Limits of the x-axis. 
    xlim_ = [Inf -Inf]; 
    % Axes for the plot. 
    ax_ = axes; 
    set(ax_,'Units','normalized','OuterPosition',[0 0 1 1]); 
    set(ax_,'Box','on'); 
    axes(ax_); 
    hold on; 
     
    % --- Plot data that was originally in data set "Y vs. X" 
    X = X(:); 
    Y = Y(:); 
    h_ = line(X,Y,'Parent',ax_,'Color',[0.333333 0 0.666667],... 
        'LineStyle','none', 'LineWidth',1,... 
        'Marker','.', 'MarkerSize',12); 
    xlim_(1) = min(xlim_(1),min(X)); 
    xlim_(2) = max(xlim_(2),max(X)); 
    legh_(end+1) = h_; 
    legt_{end+1}z = 'Y vs. X'; 
     
    % Nudge axis limits beyond data limits 
    if all(isfinite(xlim_)) 
        xlim_ = xlim_ + [-1 1] * 0.01 * diff(xlim_); 
        set(ax_,'XLim',xlim_) 
    else 
        set(ax_, 'XLim',[74.819999999999993, 93.180000000000007],'FontSize', 30); 
    end 
     
    % --- Create fit "fit 1" 
    fo_ = fitoptions('method','SmoothingSpline','SmoothingParam',0.991); 
    ok_ = isfinite(X) & isfinite(Y); 
    if ~all( ok_ ) 
        warning( 'GenerateMFile:IgnoringNansAndInfs',... 
            'Ignoring NaNs and Infs in data.' ); 
    end 
    ft_ = fittype('smoothingspline'); 
     
    % Fit this model using new data 
    cf_ = fit(X(ok_),Y(ok_),ft_,fo_); 
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%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
     
    newX = linspace(min(X), max(X), num_pts); 
     
    my_y = (cf_(newX)); 
    my_t = newX; 
    my_y2 = (my_y - min(my_y)) / ( max(my_y) - min(my_y) ); 
    % %     -------------------------------------------------------------------------------  
    %% Plot -dRFU/dT from Fitted Melt Data 
    %%----------------------------------------------------- 
    dy2 = -diff((cf_(newX))); 
    dt2 = my_t(2:length(my_t)); 
     
    
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%% 
     
    Melt_peak_index = find(dy2 == max(dy2(:))); 
    Melt_temp = dt2(Melt_peak_index); 
     
    %%%%%%%% 
    %1. Raw data:                   X, Y 
    %1. smoothed data:              my_t, my_y 
    %1. normalized smoothed data:   my_t, my_y2 
    %1. MELT profile:               dt2,dy2 
     
    
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%% 
     
     
    %Record Melt Data in file 
    fid = fopen(my_meltfile_name, 'a'); %a === append to existing file, w === overwrite existing fil (create new 
file) 
     
    n = size(dt2);; 
    n2 = n(2); 
     
     
    for k3 = 1:n2 
        if reactor_count==1 
            Melt_data_array(k3,1) = k3; 
            Melt_data_array(k3,2) = dt2(k3); 
            Melt_data_array(k3,reactor_count+2) = dy2(k3); 
        else 
            Melt_data_array(k3,reactor_count+2) = dy2(k3); 
        end 
         
    end 
     
    
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
    %       Record Raw Data in file 
    fid = fopen(my_rawfile_name, 'a'); %a === append to existing file, w === overwrite existing fil (create new 
file) 
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    n = size(X);; 
    n2 = n(2); 
     
     
    for k3 = 1:n2 
        if reactor_count==1 
            Raw_data_array(k3,1) = k3; 
            Raw_data_array(k3,2) = X(k3); 
            Raw_data_array(k3,reactor_count+2) = Y(k3); 
        else 
            Raw_data_array(k3,reactor_count+2) = Y(k3); 
        end 
         
    end 
    
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%% 
    %Record norm smoothed Data in file 
    fid = fopen(my_smoothedfile_name, 'a'); %a === append to existing file, w === overwrite existing fil (create 
new file) 
     
    n = size(my_t);; 
    n2 = n(2); 
     
     
    for k3 = 1:n2 
        if reactor_count==1 
            Smoothed_data_array(k3,1) = k3; 
            Smoothed_data_array(k3,2) = my_t(k3); 
            Smoothed_data_array(k3,reactor_count+2) = my_y(k3); 
        else 
            Smoothed_data_array(k3,reactor_count+2) = my_y(k3); 
        end 
         
    end 
    % % 
    
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
%%%%%%%%%%%%%%%%%%%%%%%%%% 
    %Record norm smoothed Data in file 
    fid = fopen(my_norm_smoothedfile_name, 'a'); %a === append to existing file, w === overwrite existing fil 
(create new file) 
     
    n = size(my_t);; 
    n2 = n(2); 
     
     
    for k3 = 1:n2 
        if reactor_count==1 
            Norm_smoothed_data_array(k3,1) = k3; 
            Norm_smoothed_data_array(k3,2) = my_t(k3); 
            Norm_smoothed_data_array(k3,reactor_count+2) = my_y2(k3); 
        else 
            Norm_smoothed_data_array(k3,reactor_count+2) = my_y2(k3); 
        end 
         
    end 
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    n = size(reactor_count);; 
    n2 = n(2); 
     
     
    for k3 = 1:n2 
        if reactor_count==1 
            Max_data_array(k3,1) = k3; 
            Max_data_array(k3,2) = reactor_count(k3); 
            Max_data_array(k3,reactor_count+2) = max(dy2), k3; 
        else 
            Max_data_array(k3,reactor_count+2) =  max(dy2), k3; 
        end 
         
    end 
     
end 
%%%%%%%Random Number Generation 
r1 = rand(1000,1); 
  
Rand_num_array(1,1) = 0; 
  
for sk = 1:reactor_count 
     
    Rand_num_array(:,sk) = r1(sk,1); 
end 
  
for nk = 1:reactor_count 
     
    Max_temp_index = find(Melt_data_array(:,2+nk) == max(Melt_data_array(:,2+nk))); 
    Max_temp = Melt_data_array(Max_temp_index,2); 
     
    MeltDD(nk,1)= nk; 
    MeltDD(nk,2)= Max_temp 





for pCount = 1:reactor_count 
    if ((pCount >= 1) && (pCount <= 49)) %if ((p == 1) || (p == 2) || (p == 4) || (p == 5)) % if((p == 1) && (p == 
2) && (p == 4) && (p == 5)) 
        if ((pCount == 2))% || (pCount ==9)) 
            hold on; 
plot(Norm_smoothed_data_array(:,2),Norm_smoothed_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCo
unt-1) Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize', 1); 
        else 
            if (pCount == 1) 
                figure( 'Name', 'Normalized Smoothed Data' ); 
                plot(Norm_smoothed_data_array(:,2),Norm_smoothed_data_array(:,pCount+2), 'Color',[0 0 0],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
                 
                xlabel( 'Temperature', 'FontSize', 25 ); 
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                ylabel( 'Ultra Fitted -dRFU/dT', 'FontSize', 25 ); 
                grid off; 
            else 
                hold on; 
plot(Norm_smoothed_data_array(:,2),Norm_smoothed_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCo
unt-2) Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
            end 
        end 
    else 
        if ((pCount == 14) || (pCount==19)) 
            hold on; 
plot(Norm_smoothed_data_array(:,2),Norm_smoothed_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCo
unt-2) Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
        else 
            hold on; 
plot(Norm_smoothed_data_array(:,2),Norm_smoothed_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCo
unt-2) Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
             
        end 
         
         
    end 
end 
  
for pCount = 1:reactor_count 
    if ((pCount >= 1) && (pCount <= 49)) %if ((p == 1) || (p == 2) || (p == 4) || (p == 5)) % if((p == 1) && (p == 
2) && (p == 4) && (p == 5)) 
        if ((pCount == 2))% || (pCount ==9)) 
            hold on; plot(Melt_data_array(:,2),Melt_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCount-1) 
Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize', 1); 
        else 
            if (pCount == 1) 
                figure( 'Name', 'Normalized 1st Derivative Melt Data' ); 
                plot(Melt_data_array(:,2),Melt_data_array(:,pCount+2), 'Color',[0 0 0],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
                 
                xlabel( 'Temperature', 'FontSize', 25 ); 
                ylabel( 'Ultra Fitted -dRFU/dT', 'FontSize', 25 ); 
                grid off; 
            else 
                hold on; plot(Melt_data_array(:,2),Melt_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCount-2) 
Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
            end 
        end 
    else 
        if ((pCount == 14) || (pCount==19)) 
            hold on; plot(Melt_data_array(:,2),Melt_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCount-2) 
Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
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                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
        else 
            hold on; plot(Melt_data_array(:,2),Melt_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCount-2) 
Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
             
        end 
         
         
    end 
end 
for pCount = 1:reactor_count 
    if ((pCount >= 1) && (pCount <= 49)) %if ((p == 1) || (p == 2) || (p == 4) || (p == 5)) % if((p == 1) && (p == 
2) && (p == 4) && (p == 5)) 
        if ((pCount == 2))% || (pCount ==9)) 
            hold on; 
plot(Smoothed_data_array(:,2),Smoothed_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCount-1) 
Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize', 1); 
        else 
            if (pCount == 1) 
                figure( 'Name', 'Smoothed data' ); 
                plot(Smoothed_data_array(:,2),Smoothed_data_array(:,pCount+2), 'Color',[0 0 0],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
                 
                xlabel( 'Temperature', 'FontSize', 25 ); 
                ylabel( 'RFUs', 'FontSize', 25 ); 
                grid off; 
            else 
                hold on; 
plot(Smoothed_data_array(:,2),Smoothed_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCount-2) 
Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
            end 
        end 
    else 
        if ((pCount == 14) || (pCount==19)) 
            hold on; 
plot(Smoothed_data_array(:,2),Smoothed_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCount-2) 
Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
        else 
            hold on; 
plot(Smoothed_data_array(:,2),Smoothed_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCount-2) 
Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
             
        end 
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for pCount = 1:reactor_count 
    if ((pCount >= 1) && (pCount <= 49)) %if ((p == 1) || (p == 2) || (p == 4) || (p == 5)) % if((p == 1) && (p == 
2) && (p == 4) && (p == 5)) 
        if ((pCount == 2))% || (pCount ==9)) 
            hold on; plot(Melt_data_array(:,2),Melt_data_array(:,7)-
Melt_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCount-1) Rand_num_array(:,pCount) 
Rand_num_array(:,pCount-1)],... 
                'LineStyle','none', 'LineWidth',1,... 
                'Marker','.', 'MarkerSize', 1); 
        else 
            if (pCount == 1) 
                figure( 'Name', 'Normalized 1st Derivative Melt H37RV-R35 plot' ); 
                plot(Melt_data_array(:,2),Melt_data_array(:,7)-Melt_data_array(:,pCount+2), 'Color',[0 0 0],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
                 
                xlabel( 'Temperature', 'FontSize', 25 ); 
                ylabel( 'RFUs', 'FontSize', 25 ); 
                grid off; 
            else 
                hold on; plot(Melt_data_array(:,2),Melt_data_array(:,7)-
Melt_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCount-2) Rand_num_array(:,pCount) 
Rand_num_array(:,pCount-1)],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
            end 
        end 
    else 
        if ((pCount == 14) || (pCount==19)) 
            hold on; plot(Melt_data_array(:,2),Melt_data_array(:,7)-
Melt_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCount-2) Rand_num_array(:,pCount) 
Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
        else 
            hold on; plot(Melt_data_array(:,2),Melt_data_array(:,7)-
Melt_data_array(:,pCount+2),'Color',[Rand_num_array(:,pCount-2) Rand_num_array(:,pCount) 
Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
             
        end 
         




Melt_peak_index = find(dy2 == max(dy2(:))) 
Melt_temp = dt2(Melt_peak_index) 




for ck = 1:reactor_count 
    a = Melt_data_array(:,ck+2); 
    c = Melt_data_array(:,2); 
    b = max(a); 
    hmax = b/2; 
    for it2 = 1:size(a) 
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        if (a(it2) < hmax) 
            digit(it2) = 0; 
        else 
            digit(it2) = 1; 
        end 
    end 
     
    for it3 = 1: size(a)-1 
        digit2(it3) = digit(it3) - digit(it3+1); 
        if(digit2(it3) == 1) 
            t1(it3) = c(it3); 
        else 
            t1(it3) = 0; 
        end 
         
    end 
     
    for it4 = 1: size(a)-1 
        digit2(it4) = digit(it4) - digit(it4+1); 
        if(digit2(it4) == -1) 
            t2(it4) = c(it4); 
        else 
            t2(it4) = 0; 
        end 
         
    end 
    for m = 1:reactor_count 
        T1 = sum(t1); 
        T2 = sum(t2); 
        if ((T1 > 95) && (T1 < 70)) 
            T1 = 0; 
        else 
            T1 = sum(t1); 
            if ((T2 > 95) && (T2 < 70)) 
                T1 = 0; 
            else 
                T2 = sum(t2); 
            end 
        end 
         
         
        fwh_max(ck) = abs(T1-T2); 
    end 
end 
Thresh = 50; 
  
for ink=1:reactor_count 
    if(fwh_max(ink)<Thresh) 
        Fullw2(ink) = fwh_max(ink); 
    else 
        Fullw2(ink) = 0; 
    end 
end 
  
Fullw3 = (Fullw2 - min(Fullw2)) / ( max(Fullw2) - min(Fullw2) ); 
  
mksize = 50; 
for p = 1:reactor_count 
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    if ((p >= 1) && (p <= 49)) %if ((p == 1) || (p == 2) || (p == 4) || (p == 5)) % if((p == 1) && (p == 2) && (p 
== 4) && (p == 5)) 
        if ((p == 2))% || (p==9)) 
            hold on; plot(MeltDD(p,1),MeltDD(p,2),'Color',[Rand_num_array(:,p-1) Rand_num_array(:,p) 
Rand_num_array(:,p-1)],... 
                'LineStyle','none', 'LineWidth',1,... 
                'Marker','.', 'MarkerSize',mksize*Fullw3(p)+5); 
        else 
            if (p == 1) 
                figure( 'Name', 'Melt Data Display' ); 
                plot(MeltDD(p,1),MeltDD(p,2),'Color',[0 0 0],... 
                    'LineStyle','none', 'LineWidth',1,... 
                    'Marker','.', 'MarkerSize',mksize*Fullw3(p)+5); 
                xlabel( 'Reactor Number','FontSize', 25 ); 
                ylabel( 'Melting Temperature (T_M)', 'FontSize', 25 ); 
                grid on; 
            else 
                hold on; plot(MeltDD(p,1),MeltDD(p,2),'Color',[Rand_num_array(:,p-2) Rand_num_array(:,p) 
Rand_num_array(:,p-1)],... 
                    'LineStyle','none', 'LineWidth',1,... 
                    'Marker','.', 'MarkerSize',mksize*Fullw3(p)+5); 
            end 
        end 
    else 
        if ((p == 14) || (p==19)) 
            hold on; plot(MeltDD(p,1),MeltDD(p,2),'Color',[Rand_num_array(:,p-2) Rand_num_array(:,p) 
Rand_num_array(:,p-1)],... 
                'LineStyle','none', 'LineWidth',1,... 
                'Marker','.', 'MarkerSize',mksize*Fullw3(p)+5); 
        else 
            hold on; plot(MeltDD(p,1),MeltDD(p,2),'Color',[Rand_num_array(:,p-2) Rand_num_array(:,p) 
Rand_num_array(:,p-1)],... 
                'LineStyle','none', 'LineWidth',1,... 
                'Marker','.', 'MarkerSize',mksize*Fullw3(p)+5); 
             
        end 
         
        %     else    hold on; plot(MeltDD(:,1),MeltDD(:,p),'Color',[0 1 0],... 
        %             'LineStyle','none', 'LineWidth',1,... 
        %             'Marker','.', 'MarkerSize',40); 




for p = 1:reactor_count 
    if ((p >= 1) && (p <= 49)) %if ((p == 1) || (p == 2) || (p == 4) || (p == 5)) % if((p == 1) && (p == 2) && (p 
== 4) && (p == 5)) 
        if ((p == 4) || (p==9)) 
            hold on; plot(Fullw2(1:ck),'Color',[1 0 0],... 
                'LineStyle','-', 'LineWidth',1,... 
                'Marker','.', 'MarkerSize',10); 
        else 
            if (p == 1) 
                figure( 'Name', 'Full width at hmax display' ); 
                plot(Fullw2(1:ck),'Color',[0 0 0],... 
                    'LineStyle','-', 'LineWidth',1,... 
                    'Marker','.', 'MarkerSize',10); 
                xlabel( 'Reactor Number','FontSize', 25 ); 
                ylabel( 'fwhm', 'FontSize', 25 ); 
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                grid off; 
            else 
                hold on; plot(Fullw2(1:ck),'Color',[1 0 0],... 
                    'LineStyle','-', 'LineWidth',1,... 
                    'Marker','.', 'MarkerSize',10); 
            end 
        end 
    else 
        if ((p == 14) || (p==19)) 
            hold on; plot(Fullw2(1:ck),'Color',[1 0 0],... 
                'LineStyle','-', 'LineWidth',1,... 
                'Marker','.', 'MarkerSize',10); 
        else 
            hold on; plot(Fullw2(1:ck),'Color',[1 0 0],... 
                'LineStyle','-', 'LineWidth',1,... 
                'Marker','.', 'MarkerSize',10); 
             
        end 
  





for pCount = 1:reactor_count 
    if ((pCount >= 1) && (pCount <= 49)) %if ((p == 1) || (p == 2) || (p == 4) || (p == 5)) % if((p == 1) && (p == 
2) && (p == 4) && (p == 5)) 
        if ((pCount ==2))%|| (pCount ==8)) 
            hold on; plot(Amplif_Array(:,1),Amplif_Array(:,pCount+4),'Color',[Rand_num_array(:,pCount-1) 
Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize', 1); 
        else 
            if (pCount == 1) 
                figure( 'Name', 'Real Time Amplification Curves' ); 
                plot(Amplif_Array(:,1),Amplif_Array(:,pCount+4), 'Color',[0 0 0],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
                 
                xlabel( 'Cycle Number', 'FontSize', 25 ); 
                ylabel( 'RFUs', 'FontSize', 25 ); 
                grid off; 
            else 
                hold on; plot(Amplif_Array(:,1),Amplif_Array(:,pCount+4),'Color',[Rand_num_array(:,pCount-2) 
Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
            end 
        end 
    else 
        if ((pCount == 13) || (pCount==18)) 
            hold on; plot(Amplif_Array(:,1),Amplif_Array(:,pCount+4),'Color',[Rand_num_array(:,pCount-2) 
Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
        else 
            hold on; plot(Amplif_Array(:,1),Amplif_Array(:,pCount+4),'Color',[Rand_num_array(:,pCount-2) 
Rand_num_array(:,pCount) Rand_num_array(:,pCount-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
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                'Marker','.', 'MarkerSize',1); 
             
        end 
         
        
    end 
end 
  
Melt_temps_only(1,1) = 0; 
  
for mk = 1:reactor_count 
     
    Melt_temps_only(:,mk) = MeltDD(mk,2); 
end 
  
Melt_temps_map(1,1) = 0; 
  
for tk = 1:reactor_count 
     
    if ((tk >= 2) && (tk <= 12))%(tk <= 11) 
        Melt_temps_map(tk-1,1) = MeltDD(tk,2); 
         
    else 
        if ((tk >= 13) && (tk <= 23)) 
            Melt_temps_map(tk-12,2) = MeltDD(tk,2); 
             
        else 
            if ((tk >= 24) && (tk <= 34)) 
                Melt_temps_map(tk-11*2-1,3) = MeltDD(tk,2); 
                 
            else 
                if ((tk >= 35) && (tk <= 45)) 
                    Melt_temps_map(tk-11*3-1,4) = MeltDD(tk,2); 
                else 
                    if ((tk >= 46) && (tk <= 56)) 
                        Melt_temps_map(tk-11*4-1,5) = MeltDD(tk,2); 
                    else 
                        if ((tk >= 57) && (tk <= 67)) 
                            Melt_temps_map(tk-11*5-1,6) = MeltDD(tk,2); 
                        else 
                            if ((tk >= 68) && (tk <= 78)) 
                                Melt_temps_map(tk-11*6-1,7) = MeltDD(tk,2); 
                            else 
                                if ((tk >= 79) && (tk <= 89)) 
                                    Melt_temps_map(tk-11*7-1,8) = MeltDD(tk,2); 
                                else 
                                    if ((tk >= 90) && (tk <= 100)) 
                                        Melt_temps_map(tk-11*8-1,9) = MeltDD(tk,2); 
                                    else 
                                        if ((tk >= 101) && (tk <= 111)) 
                                            Melt_temps_map(tk-11*9-1,10) = MeltDD(tk,2); 
                                        else 
                                            if ((tk >= 112) && (tk <= 122)) 
                                                Melt_temps_map(tk-11*10-1,11) = MeltDD(tk,2); 
                                            else 
                                                if ((tk >= 123) && (tk <= 133)) 
                                                    Melt_temps_map(tk-11*11-1,12) = MeltDD(tk,2); 
                                                end 
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                                            end 
                                        end 
                                    end 
                                end 
                            end 
                        end 
                    end 
                end 
            end 
        end 
         
    end 
end 
%%%%%%%%%%%Maximum fluorecence vs Melt temp 
Range1_fluo_array(1,1) = 0; 
  
for rk = 1:reactor_count 
     





Max_fluo_array(1,1) = 0; 
  
for bk = 1:reactor_count 
     
    Max_fluo_array(:,bk) = max(Amplif_Array(:,bk+4)); 
end 
  
for bk = 1:reactor_count 
    if ((bk == 2))% || (bk==3)) 
        hold on; plot(Max_fluo_array(:,bk),Melt_temps_only(:,bk),'Color',[Rand_num_array(:,bk-1) 
Rand_num_array(:,bk) Rand_num_array(:,bk-1)],... 
            'LineStyle','none', 'LineWidth',1,... 
            'Marker','.', 'MarkerSize',Range1_fluo_array(:,bk)*500); 
         
    else 
        if (bk == 1) 
            figure( 'Name', 'Max Fluoresence vs Melt temp' ); 
            plot(Max_fluo_array(:,1),Melt_temps_only(:,1),'Color',[0 0 0],... 
                'LineStyle','none', 'LineWidth',1,... 
                'Marker','.', 'MarkerSize',Range1_fluo_array(:,bk)*500); 
            xlabel( 'Maximum Fluorescence','FontSize', 25 ); 
            ylabel( 'Melting Temperature (T_M)', 'FontSize', 25 ); 
            grid on; 
            axis([0.3 0.38 74 92]); 
        else 
            hold on; plot(Max_fluo_array(:,bk),Melt_temps_only(:,bk),'Color',[Rand_num_array(:,bk-2) 
Rand_num_array(:,bk) Rand_num_array(:,bk-1)],... 
                'LineStyle','none', 'LineWidth',1,... 
                'Marker','.', 'MarkerSize',Range1_fluo_array(:,bk)*500); 
             
        end 
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for pk = 1:reactor_count 
    if ((pk == 2))% || (bk==3)) 
        hold on; plot(Range1_fluo_array(:,pk),Melt_temps_only(:,pk),'Color',[Rand_num_array(:,pk-1) 
Rand_num_array(:,pk) Rand_num_array(:,pk-1)],... 
            'LineStyle','none', 'LineWidth',1,... 
            'Marker','.', 'MarkerSize',20); 
         
    else 
        if (pk == 1) 
            figure( 'Name', 'Amplification Range vs Melt temp' ); 
            plot(Range1_fluo_array(:,pk),Melt_temps_only(:,pk),'Color',[0 0 0],... 
                'LineStyle','none', 'LineWidth',1,... 
                'Marker','.', 'MarkerSize',20); 
            xlabel( 'Amplification Range','FontSize', 25 ); 
            ylabel( 'Melting Temperature (T_M)', 'FontSize', 25 ); 
            grid on; 
            axis([0 0.08 74 92]); 
        else 
            hold on; plot(Range1_fluo_array(:,pk),Melt_temps_only(:,pk),'Color',[Rand_num_array(:,pk-2) 
Rand_num_array(:,pk) Rand_num_array(:,pk-1)],... 
                'LineStyle','none', 'LineWidth',1,... 
                'Marker','.', 'MarkerSize',20); 
             
        end 
         
    end 
end 
  
Cleaned_Norm_smoothed_data_array(10000,129) = 0; 
Cleaned_Melt_data_array(9999,129) = 0; 
  
for pk = 1:reactor_count 
     
    if Max_fluo_array(:,pk) > 0.29 
        Cleaned_Norm_smoothed_data_array(:,pk) = Norm_smoothed_data_array(:,pk+2); 
        Cleaned_Melt_data_array(:,pk) = Melt_data_array(:,pk+2); 
    end 
end 
  
for zk = 1:reactor_count 
    if ((zk >= 1) && (zk <= 49)) %if ((p == 1) || (p == 2) || (p == 4) || (p == 5)) % if((p == 1) && (p == 2) && (p 
== 4) && (p == 5)) 
        if ((zk == 2))% || (pCount ==9)) 
            hold on; 
plot(Norm_smoothed_data_array(:,2),Cleaned_Norm_smoothed_data_array(:,zk),'Color',[Rand_num_array(:,zk-
1) Rand_num_array(:,zk) Rand_num_array(:,zk-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize', 1); 
        else 
            if (zk == 1) 
                figure( 'Name', 'Normalized Smoothed Data' ); 
                plot(Norm_smoothed_data_array(:,2),Cleaned_Norm_smoothed_data_array(:,zk), 'Color',[1 1 1],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
                 
                xlabel( 'Temperature', 'FontSize', 25 ); 
                ylabel( 'Ultra Fitted -dRFU/dT', 'FontSize', 25 ); 
                grid off; 
            else 
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                hold on; 
plot(Norm_smoothed_data_array(:,2),Cleaned_Norm_smoothed_data_array(:,zk),'Color',[Rand_num_array(:,zk-
2) Rand_num_array(:,zk) Rand_num_array(:,zk-1)],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
            end 
        end 
    else 
        if ((zk == 14) || (zk==19)) 
            hold on; 
plot(Norm_smoothed_data_array(:,2),Cleaned_Norm_smoothed_data_array(:,zk),'Color',[Rand_num_array(:,zk-
2) Rand_num_array(:,zk) Rand_num_array(:,zk-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
        else 
            hold on; 
plot(Norm_smoothed_data_array(:,2),Cleaned_Norm_smoothed_data_array(:,zk),'Color',[Rand_num_array(:,zk-
2) Rand_num_array(:,zk) Rand_num_array(:,zk-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
             
        end 
         
         
    end 
end 
  
for zk = 1:reactor_count 
    if ((zk >= 1) && (zk <= 49)) %if ((p == 1) || (p == 2) || (p == 4) || (p == 5)) % if((p == 1) && (p == 2) && (p 
== 4) && (p == 5)) 
        if ((zk == 2))% || (pCount ==9)) 
            hold on; plot(Melt_data_array(:,2),Cleaned_Melt_data_array(:,zk),'Color',[Rand_num_array(:,zk-1) 
Rand_num_array(:,zk) Rand_num_array(:,zk-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize', 1); 
        else 
            if (zk == 1) 
                figure( 'Name', 'Cleaned 1st Derivative Melt Data' ); 
                plot(Melt_data_array(:,2),Cleaned_Melt_data_array(:,zk), 'Color',[1 1 1],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
                 
                xlabel( 'Temperature', 'FontSize', 25 ); 
                ylabel( 'Ultra Fitted -dRFU/dT', 'FontSize', 25 ); 
                grid off; 
            else 
                hold on; plot(Melt_data_array(:,2),Cleaned_Melt_data_array(:,zk),'Color',[Rand_num_array(:,zk-2) 
Rand_num_array(:,zk) Rand_num_array(:,zk-1)],... 
                    'LineStyle','-', 'LineWidth',2,... 
                    'Marker','.', 'MarkerSize', 1); 
            end 
        end 
    else 
        if ((zk == 14) || (zk==19)) 
            hold on; plot(Melt_data_array(:,2),Cleaned_Melt_data_array(:,zk),'Color',[Rand_num_array(:,zk-2) 
Rand_num_array(:,zk) Rand_num_array(:,zk-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
        else 
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            hold on; plot(Melt_data_array(:,2),Cleaned_Melt_data_array(:,zk),'Color',[Rand_num_array(:,zk-2) 
Rand_num_array(:,zk) Rand_num_array(:,zk-1)],... 
                'LineStyle','-', 'LineWidth',2,... 
                'Marker','.', 'MarkerSize',1); 
             
        end 
         
         









fname = 'C:\Users\High_Resolution_MeltRecords.xls''; 
fname2 = 'C:\Users\ Real_time_PCR_Records.xls'; 
nplots = 180;    %number of graphs to plot 
nrows = 6;      %number of rows 
ncols = 6;      %numer of columns 
  
num = dlmread(fname); %This is just the original dataset 
num2 = dlmread(fname2);%Amplification 
  
myx = Norm_smoothed_data_array(:,2); %X values 
myx2 = num2(:,1); 
myx3 = Melt_data_array(:,2); 
  
plotCount = 0; 
for count=25:nplots 
     
     
    myy = Norm_smoothed_data_array(:,3+count); %Y values melts 
    myy2 = num2(:,5+count); 
    myy3 = Melt_data_array(:,3+count); 
     
    if (count == 1) 
        figure         
    end 
     
    %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
    if(count<15) 
        mcolor = 'ko'; %specify marker color 
        mfc = [0 0 0]; %specify marker face color 
    else 
        mcolor = 'ko'; 
        mfc = [0 0 0]; 
    end 
     
    %Optional: For changing the thickness of some graphs. For instance, here we 
    %increase the thickness of every 7th reactor 
     
    mksize = 2; 
    plotCount = plotCount+1; 
    subplot(nrows,ncols,plotCount)    %Here you specify the dumensions of the plot grid 
 
  School of LM & MS                                           114                                                        University of KwaZulu-Natal 
 
  
    plot(myx2,myy2, mcolor,... 
        'MarkerFaceColor',mfc,... 
        'MarkerSize',mksize); 
    grid on 
    axis([1 35 0.27 0.9]); 
    set(gca,'XGrid','on','YGrid','on', 'GridLineStyle','-'); 
    title(num2str(count)); 
     
     
     plotCount = plotCount+1; 
    subplot(nrows,ncols,plotCount)    %Here you specify the dumensions of the plot grid 
  
    plot(myx,myy, mcolor,... 
        'MarkerFaceColor',mfc,... 
        'MarkerSize',mksize); 
    grid on 
    axis([75 90 0 1]); 
    set(gca,'XGrid','on','YGrid','on', 'GridLineStyle','-'); 
    title(num2str(Melt_temps_only(count+1))); 
     
    plotCount = plotCount+1; 
    subplot(nrows,ncols,plotCount)    %Here you specify the dumensions of the plot grid 
  
    plot(myx3,myy3, mcolor,... 
        'MarkerFaceColor',mfc,... 
        'MarkerSize',mksize); 
    grid on 
    axis([75 90 -0.5E-5 10E-5]); 
    set(gca,'XGrid','on','YGrid','on', 'GridLineStyle','-'); 
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